DVT of lower extremities and pulmonary embolism

I9_DVTANDPULM

No definition available.

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	519972
1. Apply sex-specific rule None	519972
2. Check conditions None	519972
3. Check pre-conditions, main-only, mode, registry filters None 0 out of 7 registries used, show all original rules.	0
4. Check minimum number of events None	0
5. Include endpoints I9_PHLETHROMBDVTLOW I9_PULMEMB	21224
6. Filter based on genotype QC (FinnGen only)	20624

Control definitions (FinnGen only)

Controls for this endpoint are individuals that are not cases.

Extra metadata

Level in the ICD hierarchy: C
First used in FinnGen datafreeze: DF9

NAME	I9_DVTANDPULM
CONTROL_EXCLUDE
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE	I9_PHLETHROMBDVTLOW\|I9_PULMEMB
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10
HD_ICD_9
HD_ICD_8
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10
COD_ICD_9
COD_ICD_8
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to DVT of lower extremities and pulmonary embolism based on the number of shared cases.

Similar with more cases:

Similar with less cases:

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	20624	10720	9904
Unadjusted period prevalence (%)	4.16	3.80	4.54
Median age at first event (years)	63.82	62.69	65.04

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
21221: Matched controls
211282

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

M79.6

ICD-10 Finland

Pain in limb

1.7

315.0

8807

61170

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

2.1

307.7

4360

23022

J18.9

ICD-10 Finland

Pneumonia, unspecified

2.1

307.7

6892

39658

K93

ICPC

Pulmonary embolism

99.8

307.7

1326

141

R06.0

ICD-10 Finland

Dyspnoea

2.7

307.7

7923

38694

FB1AD

NOMESCO Finland

CT examination of arteria pulmonalis

7.6

307.7

1114

1522

4511A

ICD-9 Finland

Phlebitis and thrombophlebitis, Of deep vessels of lower extremities

+∞

307.7

1366

B01AB05

ATC

enoxaparin; parenteral

4.1

307.7

11294

45951

B01AB04

ATC

dalteparin; parenteral

4.1

307.7

2021

5326

B01AF01

ATC

rivaroxaban; oral

3.3

307.7

4590

16308

D68.8

ICD-10 Finland

Other specified coagulation defects

14.7

307.7

659

459

I26

ICD-10 Finland

Pulmonary embolism

110.6

307.7

1245

119

379

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the long-term prevention of recurrent deep veinthrombosis and pulmonary embolism

96.4

307.7

3961

502

JN4BD

NOMESCO Finland

Extensive body CT

2.3

307.7

2786

12946

I82.88

ICD-10 Finland

Embolism and thrombosis of other specified veins

11.4

307.7

1160

1062

166

Kela drug reimbursment

Dalteparin and tinzaparin (treatment for more than 6 months)

32.6

307.7

847

269

I26.0

ICD-10 Finland

Pulmonary embolism with mention of acute cor pulmonale

1469.6

307.7

3664

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

2.7

307.7

3875

16110

B01AB10

ATC

tinzaparin; parenteral

3.9

307.7

3662

10845

B01AA03

ATC

warfarin; systemic

5.6

307.7

9884

28624

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

6.5

307.7

6226

12607

GD1AA

NOMESCO Finland

Thorax X-ray examination

2.1

307.7

11452

75154

I80.20

ICD-10 Finland

Phlebitis and thrombophlebitis in the iliac vein

435.8

307.7

678

GD2SN

NOMESCO Finland

Lung ventilation SPECT

13.6

307.7

419

312

K94

ICPC

Phlebitis/thrombophlebitis

11.8

307.7

981

865

JN4AD

NOMESCO Finland

Body CT examination

2.3

307.7

2695

12386

N02AA05

ATC

oxycodone; systemic

2.3

307.7

5028

25563

C03CA01

ATC

furosemide; systemic

2.0

307.7

8481

53449

I26.9

ICD-10 Finland

Pulmonary embolism without mention of acute cor pulmonale

1860.8

307.7

11905

145

A03FA01

ATC

metoclopramide; systemic, rectal

2.0

307.7

5227

29597

I80.0

ICD-10 Finland

Phlebitis and thrombophlebitis of superficial vessels of lower extremities

5.2

307.7

1579

3189

130

Kela drug reimbursment

Malignant tumour

2.5

307.7

2464

10674

I87.0

ICD-10 Finland

Postthrombotic syndrome

30.2

307.7

252

B01AF02

ATC

apixaban; oral

3.8

307.7

5251

16976

I80.29

ICD-10 Finland

Phlebitis and thrombophlebitis of other deep vessels of lower extremities

117.9

307.7

5472

621

I80.8

ICD-10 Finland

Phlebitis and thrombophlebitis of other sites

7.1

307.7

661

951

I80.1

ICD-10 Finland

Phlebitis and thrombophlebitis of femoral vein

217.7

307.7

2302

118

GD1UN

NOMESCO Finland

Lung circulation SPECT

14.3

307.7

358

254

4151A

ICD-9 Finland

Acute pulmonary heart disease, Pulmonary embolism and infarction

+∞

307.7

464

H02AB02

ATC

dexamethasone; systemic

2.5

307.7

2966

13088

I82.9

ICD-10 Finland

Embolism and thrombosis of unspecified vein

10.7

307.7

1109

1082

A49.9

ICD-10 Finland

Bacterial infection, unspecified

2.2

307.7

3077

14842

I80.3

ICD-10 Finland

Phlebitis and thrombophlebitis of lower extremities, unspecified

10.2

307.7

2611

2859

R60.0

ICD-10 Finland

Localized oedema

2.2

307.7

3281

16130

I80.9

ICD-10 Finland

Phlebitis and thrombophlebitis of unspecified site

8.6

307.7

726

869

WD125

NOMESCO Finland

Demanding cystostatic therapy of methastized malignancy

3.3

307.7

1309

4117

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

9.2

307.7

5101

6996

TPH04

NOMESCO Finland

Cathetrisation of vein

1.9

303.0

5118

30531

N02AX02

ATC

tramadol; systemic, rectal

1.7

301.6

9576

68622

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

1.9

300.2

4618

26710

Z51.5

ICD-10 Finland

Palliative care

2.4

299.1

2266

9978

H02AB06

ATC

prednisolone; systemic

1.7

281.5

10330

76425

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

2.2

279.3

2657

12867

JN3AD

NOMESCO Finland

Abdominal CT examination

2.1

265.5

2755

13789

A02BC02

ATC

pantoprazole; systemic

1.7

254.5

14385

117490

FM1AE

NOMESCO Finland

Standard cardiac ultrasound examination

1.8

252.7

4412

26383

I80.2

ICD-10 Finland

Phlebitis and thrombophlebitis of other deep vessels of lower extremities

+∞

250.1

240

A04AA01

ATC

ondansetron; systemic, rectal

2.3

240.6

1916

8587

A46

ICD-10 Finland

Erysipelas

1.9

238.3

3550

20143

R50.9

ICD-10 Finland

Fever, unspecified

1.9

233.6

3299

18380

I87.2

ICD-10 Finland

Venous insufficiency (chronic)(peripheral)

2.1

232.9

2598

13321

XF400

NOMESCO Finland

ECG with 12 standard connections

1.8

226.7

3765

22083

J01MA12

ATC

levofloxacin; systemic

1.8

225.5

4286

26181

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

1.7

224.3

5175

33393

WD105

NOMESCO Finland

Cystostatic therapy of methastized malignancy

3.0

224.1

1075

3753

I80

ICD-10 Finland

Phlebitis and thrombophlebitis

5.5

220.9

430

787

JN3BD

NOMESCO Finland

Extensive abdominal CT

2.1

205.4

2324

11946

A04AA02

ATC

granisetron; systemic, transdermal

2.4

204.4

1501

6476

45001

ICD-8 Finland

Pulmonary embolism and infarction, Embolia

+∞

200.0

192

N02AJ06

ATC

codeine and paracetamol; systemic

1.6

197.6

8190

60668

R02

ICPC

Shortness of breath/dyspnoea

1.9

194.3

2922

16536

AA1AD

NOMESCO Finland

CT of head and brain

1.6

193.1

6101

42382

N03AX16

ATC

[U] pregabalin

1.7

191.8

4935

32565

TPH07

NOMESCO Finland

Cathetrisation of artery

1.9

189.2

2599

14270

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

1.6

187.5

6270

44083

45100

ICD-8 Finland

Phlebitis and thrombophlebitis, Of lower extremities

6.0

186.0

333

563

TPH15

NOMESCO Finland

Insertion of central venous catheter through external or internal jugular vein

2.3

184.2

1475

6601

R4110

NOMESCO Finland

Physiotherapy

1.6

180.4

5714

39591

WF049

NOMESCO Finland

Radiotherapy of metastasis

2.8

178.2

937

3431

N02BE01

ATC

paracetamol; systemic, rectal

1.8

176.9

18333

164849

TPX10

NOMESCO Finland

Implantation of vascular injection port

3.1

175.3

768

2542

J45.9

ICD-10 Finland

Asthma, unspecified

1.7

171.6

3875

24615

R91

ICD-10 Finland

Abnormal findings on diagnostic imaging of lung

1.9

169.8

2397

13250

GD1AD

NOMESCO Finland

Thorax CT examination

2.3

169.5

1373

6169

C79.8

ICD-10 Finland

Secondary malignant neoplasm of other specified sites

2.7

169.3

922

3438

ZX120

NOMESCO Finland

Intravenous

2.0

167.8

2081

11009

I27.2

ICD-10 Finland

Other secondary pulmonary hypertension

7.8

166.2

231

298

R03AC02

ATC

salbutamol; inhalant

1.5

164.5

10497

84035

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

1.8

163.9

3066

18461

L01BC06

ATC

capecitabine; oral

2.6

162.7

955

3698

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

1.5

160.5

7197

53563

WX892

NOMESCO Finland

Monitored bed care

2.1

159.3

1734

8749

ZXD05

NOMESCO Finland

Urgent procedure

1.5

158.9

6077

43700

E66.01

ICD-10 Finland

Obesity due to excess calories

2.1

157.7

1589

7787

UGC12

NOMESCO Finland

Flexible bronchoscopy

2.0

156.0

1818

9400

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

1.5

155.0

8725

67853

WX408

NOMESCO Finland

General anesthesy, balanced

1.6

149.1

5109

35764

K99

ICPC

Cardiovascular disease other

2.8

149.0

753

2697

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

1.7

149.0

3423

21754

J01DB01

ATC

cefalexin; oral

1.6

148.5

16440

145475

WD405

NOMESCO Finland

Simple antiboidy therapy of methastized malignancy

3.2

147.8

598

1887

WZC00

NOMESCO Finland

Treatment plan or consultation

1.5

147.4

6835

50996

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

1.7

146.0

3249

20466

J01FF01

ATC

clindamycin; systemic

1.5

145.6

5305

37607

R03BB04

ATC

tiotropium bromide; inhalant

1.8

144.8

2342

13473

R07.4

ICD-10 Finland

Chest pain, unspecified

1.5

143.0

5831

42311

C78.7

ICD-10 Finland

Secondary malignant neoplasm of liver and intrahepatic bile duct

3.1

141.7

628

2091

D68.9

ICD-10 Finland

Coagulation defect, unspecified

10.2

141.6

159

156

J01MA14

ATC

moxifloxacin; systemic

1.9

138.4

1898

10356

I50.9

ICD-10 Finland

Heart failure, unspecified

1.6

137.9

3516

22900

I82

ICD-10 Finland

Other venous embolism and thrombosis

12.1

137.8

138

114

N02AB03

ATC

fentanyl; nasal, sublingual, transdermal

2.3

136.9

1137

5151

J15.9

ICD-10 Finland

Bacterial pneumonia, unspecified

1.9

136.6

2061

11591

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

1.5

135.9

6818

51468

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

1.5

134.9

6563

49232

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

1.6

134.9

3702

24536

J01MA02

ATC

ciprofloxacin; systemic

1.4

134.8

8055

62836

SPAT1254

SPAT

Administration of medicine

1.7

134.8

3172

20233

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

1.6

133.9

3494

22870

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

1.9

133.0

1873

10302

A28

ICPC

Limited function/disability NOS

1.6

131.7

3901

26309

SPAT1148

SPAT

Treatment of chronic ulcer or burn

1.7

131.3

2939

18493

I27.8

ICD-10 Finland

Other specified pulmonary heart diseases

10.3

130.8

146

142

L28

ICPC

Limited function/disability (L)

1.6

130.3

3879

26183

Z3226

NOMESCO Finland

Physiotherapist

1.6

130.2

3628

24110

D68.2

ICD-10 Finland

Hereditary deficiency of other clotting factors

13.6

129.6

121

GD1DD

NOMESCO Finland

High resolution CT examination of lungs

2.2

129.0

1139

5290

R60.9

ICD-10 Finland

Oedema, unspecified

2.1

126.5

1249

6059

WZC30

NOMESCO Finland

Teaching

1.6

125.6

3098

19965

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

1.8

123.1

2148

12602

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

1.6

121.7

3249

21334

O22.3

ICD-10 Finland

Deep phlebothrombosis in pregnancy

28.3

121.7

J96.1

ICD-10 Finland

Chronic respiratory failure

2.9

120.1

582

2036

WX302

NOMESCO Finland

Thoracal epidural anesthesy

2.1

120.0

1150

5513

L14

ICPC

Leg/thigh symptom/complaint

1.9

119.9

1656

9039

GD1BD

NOMESCO Finland

Thorax extensive CT-examination

2.1

119.2

1130

5395

XX3DW

NOMESCO Finland

Time consuming IT work

1.8

118.7

2167

12875

ZXE10

NOMESCO Finland

More than one and less than three hours

1.4

118.1

7026

54399

X59

ICD-10 Finland

Exposure to unspecified factor

1.6

117.1

3555

24034

L17

ICPC

Foot/toe symptom/complaint

1.5

117.0

5473

40504

R03AK06

ATC

salmeterol and fluticasone; inhalant

1.6

113.3

2819

18166

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

1.4

113.0

5792

43558

Z3231

NOMESCO Finland

Registered nurse

1.5

111.4

5357

39788

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.4

110.9

9390

76980

A06AD11

ATC

lactulose; oral

1.6

108.9

3305

22302

PG1DE

NOMESCO Finland

Other extensive ultrasound examination of artery

2.1

108.7

1038

4966

SPAT1255

SPAT

Intravenous administration of medicine

1.9

108.6

1433

7697

M04AA01

ATC

allopurinol; systemic

1.6

108.3

2910

19088

R53

ICD-10 Finland

Malaise and fatigue

1.5

107.8

4673

33981

WW500

NOMESCO Finland

Blood transfusion

2.3

107.3

879

3954

S97

ICPC

Chronic ulcer skin

1.9

106.6

1350

7151

C78.0

ICD-10 Finland

Secondary malignant neoplasm of lung

3.1

106.5

465

1534

A08

ICPC

Swelling

2.1

106.2

1136

5671

128

Kela drug reimbursment

Cancers of female genital organs

3.2

106.2

421

1312

DM1QA

NOMESCO Finland

Paranasal sinuses X-ray examination in one projection

2.2

105.2

885

4025

SPAT1229

SPAT

Assessment of need for aid

1.8

104.8

1740

10038

E66.8

ICD-10 Finland

Other obesity

2.2

104.7

943

4408

UJF32

NOMESCO Finland

Coloscopy

1.4

104.2

5271

39432

TFC00

NOMESCO Finland

Catheterisation of right atrium or ventricle

3.3

103.7

394

1196

I83.0

ICD-10 Finland

Varicose veins of lower extremities with ulcer

2.7

102.8

577

2181

PH7FT

NOMESCO Finland

Inmplantation of filter to inferior vena cava with radiological guidance

154.4

102.0

108

NK6QA

NOMESCO Finland

Measurement of bone density from two or more locations with X-ray

2.0

101.8

1247

6529

JN3AA

NOMESCO Finland

Abdominal X-ray examination without contrast

2.1

98.9

975

4720

SPAT1263

SPAT

Sampling

1.4

98.5

7854

63361

B01AX05

ATC

fondaparinux; parenteral

4.2

98.2

262

624

A06AH03

ATC

naloxegol; oral

3.4

97.0

360

1077

H02AB07

ATC

prednisone; oral

1.6

96.7

2748

18223

TPH20

NOMESCO Finland

Insertion of central venous catheter through subclavian or brachiocephalic vein

2.5

96.6

607

2425

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

1.5

96.2

3158

21625

J90

ICD-10 Finland

Pleural effusion, not elsewhere classified

2.2

96.0

807

3667

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

1.7

94.3

1938

11856

Z2446

NOMESCO Finland

Social worker

1.9

93.6

1184

6262

PH2AE, ,

SPAT

3.3

93.5

359

1097

PH2DE

NOMESCO Finland

Ultrasound examination of bloodflow in veins of lower extremity with Doppler method

2.6

93.2

567

2230

ZXE20

NOMESCO Finland

More than three and less than five hours

1.6

92.6

2638

17492

WX882

NOMESCO Finland

High dependency care

2.5

92.3

594

2400

PH1AE

NOMESCO Finland

Ultrasound examination of upper extremity veins

3.1

92.0

395

1291

L04AA06

ATC

mycophenolic acid; systemic

3.1

91.7

401

1324

A41.9

ICD-10 Finland

Sepsis, unspecified

2.2

91.4

810

3760

N05CF01

ATC

zopiclone; oral

1.4

91.0

6522

51554

203

Kela drug reimbursment

Chronic asthma and similar chronic obstructive pulmonary diseases

1.5

90.0

3732

26773

Z86.7

ICD-10 Finland

Personal history of diseases of the circulatory system

19.4

89.8

N03AX12

ATC

[U] gabapentin; oral

1.5

89.7

3067

21158

A04AA55

ATC

palonosetron, combinations; systemic

2.4

88.4

643

2746

SPAT1222

SPAT

Counselling/guidance promoting independent living

1.5

87.6

3133

21805

C03DA01

ATC

spironolactone; oral

1.6

87.6

2549

16966

L03AA02

ATC

filgrastim; parenteral

2.4

87.4

620

2619

R11

ICD-10 Finland

Nausea and vomiting

1.7

87.1

1620

9635

JN4CD

NOMESCO Finland

Very extensive body CT

2.2

87.0

793

3721

GA4YT

NOMESCO Finland

Puncture of pleura with ultrasound guidance

2.2

86.3

716

3235

QX2XE

NOMESCO Finland

Ultrsound examination of soft tissue not elsewhere classified

2.4

85.7

612

2593

ZXE03

NOMESCO Finland

Procedure duration 20 to 29 minutes

1.9

84.5

1093

5820

O99.1

ICD-10 Finland

Other diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism complicating pregnancy, childbirth and the puerperium

7.9

84.0

115

146

J01FA06

ATC

roxithromycin; oral

1.3

83.9

7370

59919

O99.4

ICD-10 Finland

Diseases of the circulatory system complicating pregnancy, childbirth and the puerperium

9.4

83.4

105

N17.9

ICD-10 Finland

Acute renal failure, unspecified

2.0

83.3

919

4633

L03AA13

ATC

pegfilgrastim; parenteral

2.1

82.5

822

3991

NG1AA

NOMESCO Finland

Knee X-ray examination without contrast

1.6

82.5

2351

15562

R52.9

ICD-10 Finland

Pain, unspecified

1.7

81.8

1800

11192

I27.9

ICD-10 Finland

Pulmonary heart disease, unspecified

5.3

81.4

164

310

GD1CQ

NOMESCO Finland

Lung circulation SPECT with low dose CT

13.3

81.3

ZXE00

NOMESCO Finland

One hour or less

1.3

81.0

7151

58104

TKC20

NOMESCO Finland

Catheterisation of bladder

1.7

80.7

1454

8567

J44.8

ICD-10 Finland

Other specified chronic obstructive pulmonary disease

1.6

80.4

2123

13800

4538X

ICD-9 Finland

Other venous embolism and thrombosis, Of other specified veins

7.9

80.2

110

140

C78.6

ICD-10 Finland

Secondary malignant neoplasm of retroperitoneum and peritoneum

3.6

80.1

268

750

WX602

NOMESCO Finland

Repeated or continuing anesthesia shots throug a catheter

1.8

79.9

1393

8130

XF600

NOMESCO Finland

Bloodpressure measurement

1.8

79.0

1220

6869

H02AB04

ATC

methylprednisolone; systemic

1.5

78.8

2714

18708

TGC00

NOMESCO Finland

Bronchial lavation

2.4

78.8

555

2337

N18.9

ICD-10 Finland

Chronic kidney disease, unspecified

1.7

78.2

1394

8185

TPH30

NOMESCO Finland

Insertion of central venous catheter through periferal vein

2.9

77.4

381

1344

I27.0

ICD-10 Finland

Primary pulmonary hypertension

8.3

77.4

101

121

PH2BC

NOMESCO Finland

Extensive flebography of lower extremity with X-ray

34.9

77.3

C02KX05

ATC

riociguat; oral

758.1

77.2

N05BA04

ATC

oxazepam; oral

1.4

77.1

4799

36877

R4190

NOMESCO Finland

Nutritional therapy

2.2

77.0

634

2855

S18

ICPC

Laceration/cut

1.3

76.8

8620

72306

I83.1

ICD-10 Finland

Varicose veins of lower extremities with inflammation

2.5

76.8

477

1895

X58

ICD-10 Finland

Exposure to other specified factors

1.5

76.7

2359

15867

WF004

NOMESCO Finland

Palliative radiotherapy

2.5

76.3

478

1906

AA1CG

NOMESCO Finland

Extensive MRI examination of brain with high intensity magnet

1.7

75.5

1399

8301

J44.0

ICD-10 Finland

Chronic obstructive pulmonary disease with acute lower respiratory infection

1.9

75.4

1017

5488

XG412

NOMESCO Finland

Flow-volume spirometry with bronchospasmolysis

1.9

75.1

1032

5601

A04.7

ICD-10 Finland

Enterocolitis due to Clostridium difficile

2.3

74.8

580

2547

H02AB09

ATC

hydrocortisone; systemic

2.6

74.2

442

1720

C02KX04

ATC

macitentan; oral

19.3

74.2

KH1AE

NOMESCO Finland

Urinary tract ultrasound examination

1.8

74.1

1203

6872

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

2.0

74.1

805

4035

E66.2

ICD-10 Finland

Extreme obesity with alveolar hypoventilation

3.6

73.9

245

682

C07AB07

ATC

bisoprolol; oral

1.3

73.7

10006

85941

A02BC01

ATC

omeprazole; systemic

1.4

73.5

5285

41493

A41.5

ICD-10 Finland

Sepsis due to other Gram-negative organisms

2.0

72.9

773

3840

J45.1

ICD-10 Finland

Nonallergic asthma

1.7

72.7

1333

7886

117

Kela drug reimbursment

Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue

1.9

72.4

888

4643

G47.3

ICD-10 Finland

Sleep apnoea

1.4

72.2

3942

29589

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

1.7

72.2

1286

7546

N06AX11

ATC

mirtazapine; oral

1.3

71.5

6145

49504

N05AH04

ATC

quetiapine; oral

1.5

71.4

2861

20294

N06AX16

ATC

venlafaxine; oral

1.5

71.4

2186

14671

127

Kela drug reimbursment

Transplant complication

3.0

71.0

310

1023

L04AX01

ATC

azathioprine; systemic

2.0

70.8

755

3758

ZXE04

NOMESCO Finland

Procedure duration 30 to 39 minutes

1.8

70.7

1071

5992

XF603

NOMESCO Finland

Direct intraarterial blood pressure measurement

2.0

70.4

775

3902

J01DA01

ATC

[U] cefalexin

1.3

70.4

11643

102355

DM1AA

NOMESCO Finland

Paranasal sinuses X-ray examination without contrast

2.2

70.0

628

2927

XG466

NOMESCO Finland

Sleep oxymetry

2.2

69.8

615

2846

I74.3

ICD-10 Finland

Embolism and thrombosis of arteries of lower extremities

3.2

69.7

277

865

L97

ICD-10 Finland

Ulcer of lower limb, not elsewhere classified

2.0

69.3

809

4157

SPAT1137

SPAT

Taking care of patient’s/customer’s hygiene

1.7

69.3

1309

7805

D50.9

ICD-10 Finland

Iron deficiency anaemia, unspecified

1.6

69.1

1528

9495

J94.8

ICD-10 Finland

Other specified pleural conditions

2.6

68.9

392

1492

QDB10

NOMESCO Finland

Major dressing of wound of skin of lower limb

1.8

68.3

1018

5667

A02BC05

ATC

esomeprazole; systemic

1.3

67.8

7540

62837

NE1AA

NOMESCO Finland

Pelvis X-ray examination

1.7

67.8

1473

9113

F32.9

ICD-10 Finland

Depressive episode, unspecified

1.6

67.7

1887

12394

UKC02

NOMESCO Finland

Cystoscopy

1.4

67.7

3238

23717

R58

ICD-10 Finland

Haemorrhage, not elsewhere classified

2.8

67.3

333

1179

M17.1

ICD-10 Finland

Other primary gonarthrosis

1.4

67.2

4169

31908

WZC20

NOMESCO Finland

Multidisciplinary treatment meeting

1.8

67.0

1038

5845

I50.0

ICD-10 Finland

Congestive heart failure

1.6

67.0

1711

11013

J46

ICD-10 Finland

Status asthmaticus

2.2

66.1

554

2513

T36

ICD-10 Finland

Poisoning by systemic antibiotics

2.1

66.1

661

3213

M05BX04

ATC

denosumab; parenteral

1.7

66.1

1209

7143

PH2AC

NOMESCO Finland

Flebography of lower extremity with X-ray

13.1

66.1

J45.0

ICD-10 Finland

Predominantly allergic asthma

1.7

65.9

1384

8486

FB1BC

NOMESCO Finland

Extensive angiography of arteria pulmonalis

16.6

65.6

M10.9

ICD-10 Finland

Gout, unspecified

1.7

65.5

1379

8460

ZXE05

NOMESCO Finland

Procedure duration 40 to 49 minutes

1.9

65.0

906

4936

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1.7

64.9

1365

8370

K07

ICPC

Swollen ankles/oedema

1.8

64.9

957

5308

E66.00

ICD-10 Finland

Metabolic syndrome

1.8

64.8

966

5375

WD115

NOMESCO Finland

Multiple cystostatic therapy of methastized malignancy

2.6

64.1

365

1390

NH1AA

NOMESCO Finland

Ankle X-ray examination without contrast

1.7

63.8

1170

6916

B01AF03

ATC

edoxaban; oral

2.3

63.4

497

2192

GD1CN

NOMESCO Finland

Lung circulation isotope imaging

20.8

63.4

R51.80

ICD-10 Finland

Headache

1.5

63.4

2398

16792

WD505

NOMESCO Finland

Simple enzyme inhibitor or similar therapy of methastized malignancy

3.3

63.4

241

733

N30.0

ICD-10 Finland

Acute cystitis

1.4

63.3

2904

21086

R03DC03

ATC

montelukast; oral

1.4

62.9

2668

19097

RT360, ,

NOMESCO Finland

15.9

62.9

R03AL01

ATC

fenoterol and ipratropium bromide; inhalant

2.1

62.8

638

3119

N06AB04

ATC

citalopram; systemic

1.4

62.4

3718

28227

GD1ED

NOMESCO Finland

Extensive high resolution CT examination of lungs

2.2

62.4

552

2559

WB113

NOMESCO Finland

Multiple adjuvant cytostatic therapy

1.9

62.3

801

4251

WD415

NOMESCO Finland

Demanding antibody therapy of methastized malignancy

2.7

62.3

331

1217

Z2221

NOMESCO Finland

Medical doctor

1.3

62.3

4833

38213

SPAT1083

SPAT

Initiation and monitoring of IV fluid therapy

1.9

62.1

859

4670

WX002

NOMESCO Finland

Sedation and analgesia

1.4

61.5

3594

27193

R03AK08

ATC

formoterol and beclometasone; inhalant

1.9

61.4

777

4102

J01EE01

ATC

sulfamethoxazole and trimethoprim; systemic

1.8

61.3

1044

6042

SPAT1301

SPAT

No procedures

1.3

61.2

5816

47290

N05BA06

ATC

lorazepam; systemic, sublingual

1.8

61.1

1009

5788

Z01.8

ICD-10 Finland

Other specified special examinations

1.4

61.0

4025

31039

M17.0

ICD-10 Finland

Primary gonarthrosis, bilateral

1.4

60.9

2743

19840

WX402

NOMESCO Finland

General anaesthesia

1.4

60.8

3480

26234

XG410

NOMESCO Finland

Flow-volume spirometry

2.0

60.8

732

3801

K78

ICPC

Atrial fibrillation/flutter

1.6

60.6

1627

10585

FB1ST

NOMESCO Finland

Catheter-based therapy of pulmonary embolism

+∞

60.3

R03BA05

ATC

fluticasone; inhalant

1.4

60.0

3067

22684

E0000UV, ,

ATC

1.3

59.8

7333

61596

WX404

NOMESCO Finland

Intravenous generell anesthesy

1.4

59.6

3390

25522

GAA10

NOMESCO Finland

Intercostal insertion of pleural drainage tube

2.5

59.4

396

1627

N05BA01

ATC

diazepam; systemic, rectal

1.5

59.2

2369

16754

P01AB01

ATC

metronidazole; oral, rectal

1.3

59.2

6917

57734

Z76.9

ICD-10 Finland

Person encountering health services in unspecified circumstances

1.6

58.8

1511

9729

K43.9

ICD-10 Finland

Other and unspecified ventral hernia without obstruction or gangrene

1.8

58.6

839

4610

R5110

NOMESCO Finland

Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it

1.5

58.1

2256

15860

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

1.4

58.0

3188

23851

ZXE06

NOMESCO Finland

Procedure duration 50 to 59 minutes

1.9

58.0

790

4272

D64.9

ICD-10 Finland

Anaemia, unspecified

1.5

57.9

2159

15057

K56.6

ICD-10 Finland

Other and unspecified intestinal obstruction

2.0

57.8

659

3359

N13.3

ICD-10 Finland

Other and unspecified hydronephrosis

2.3

57.7

445

1949

R03AL02

ATC

salbutamol and ipratropium bromide; inhalant

3.1

57.6

245

797

ZXD10

NOMESCO Finland

Scheduled procedure

1.3

57.5

7013

58795

J01AA02

ATC

doxycycline; systemic

1.3

57.5

15012

137848

SPAT1262

SPAT

Handing over of treatment supplies

1.4

57.4

3280

24698

R10.1

ICD-10 Finland

Pain localized to upper abdomen

1.4

57.2

2952

21849

R04.2

ICD-10 Finland

Haemoptysis

2.0

57.1

685

3553

C79.30

ICD-10 Finland

Secondary malignant tumor of the cerebrum

3.2

56.9

229

721

R03AK07

ATC

formoterol and budesonide; inhalant

1.4

56.9

3377

25576

1506

Kela drug reimbursment

The combination of trifluridine and tipiracil

6.3

56.5

148

E66.9

ICD-10 Finland

Obesity, unspecified

2.1

56.0

567

2769

R52.0

ICD-10 Finland

Acute pain

2.1

55.9

559

2716

K44.9

ICD-10 Finland

Diaphragmatic hernia without obstruction or gangrene

1.6

55.8

1458

9421

SPAT1216

SPAT

Assessment of functional ability

1.4

55.8

3074

22998

3018

Kela drug reimbursment

The combination of trifluridine and tipiracil

6.3

55.7

147

PH7YT

NOMESCO Finland

Dilatation of inferior vena cava or lower extremity vein with stent

101.6

55.7

45309

ICD-8 Finland

Other venous embolism and thrombosis, NUD (cerebri, cordis, mesenterii, pulmonis exceptis)

6.4

55.7

144

GD5BD

NOMESCO Finland

Thorax and upper abdomen combined extensive CT examination of

2.3

55.5

417

1807

I83.9

ICD-10 Finland

Varicose veins of lower extremities without ulcer or inflammation

1.5

55.3

1756

11845

RT172, ,

NOMESCO Finland

10.9

55.1

N05AH03

ATC

olanzapine; systemic

1.8

55.1

927

5345

SPAT1144

SPAT

Treatment of reopened or infected surgical wound

1.6

54.8

1308

8271

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.3

54.3

7005

59017

TPH90

NOMESCO Finland

Removal of fixed intravenous catheter

2.8

54.2

276

993

C79.5

ICD-10 Finland

Secondary malignant neoplasm of bone and bone marrow

2.3

54.1

431

1915

J96.0

ICD-10 Finland

Acute respiratory failure

2.7

54.0

287

1056

R03BA02

ATC

budesonide; inhalant

1.4

53.9

3002

22483

M54.5

ICD-10 Finland

Low back pain

1.3

53.8

6050

50102

W19

ICD-10 Finland

Unspecified fall

1.5

53.7

1785

12155

T82

ICPC

Obesity

2.0

53.6

588

2956

WX110

NOMESCO Finland

Infiltration anesthesia

1.3

53.3

12525

112955

NG4AA

NOMESCO Finland

Lower leg X-ray examination

2.1

53.1

546

2682

FBB20

NOMESCO Finland

Thrombendarterectomy of pulmonary artery in chronic obstruction

+∞

53.0

M54.9

ICD-10 Finland

Dorsalgia, unspecified

1.5

53.0

1974

13753

WX872

NOMESCO Finland

Intensive care

1.7

52.9

949

5570

NA3AD

NOMESCO Finland

Lumbar spine and sacrum CT examination

2.1

52.8

531

2587

Y57

ICD-10 Finland

Adverse effects in the therapeutic use of other and unspecified drugs and medicaments

2.3

52.7

388

1667

SPAT1149

SPAT

Suture or treatment of traumatic wound

1.4

52.6

2290

16430

N05AA02

ATC

levomepromazine; systemic

1.9

52.4

683

3640

ZXE30

NOMESCO Finland

More than five and less than seven hours

1.8

52.4

882

5085

R07.3

ICD-10 Finland

Other chest pain

1.5

52.3

1804

12376

SPAT1249

SPAT

Treatment-related counselling outside office

1.3

52.3

6833

57592

WX725

NOMESCO Finland

Noninvasive ventilation

1.7

52.1

919

5370

J45.8

ICD-10 Finland

Mixed asthma

2.0

51.6

554

2763

NH3AA

NOMESCO Finland

Foot and toes X-ray examination

1.6

51.4

1436

9414

ZXA05

NOMESCO Finland

Left side

1.3

51.4

4680

37665

J84.9

ICD-10 Finland

Interstitial pulmonary disease, unspecified

2.2

51.2

430

1952

JAH00

NOMESCO Finland

Laparotomy

2.0

51.2

533

2629

JAL30

NOMESCO Finland

Omentectomy

3.0

50.8

233

792

ZX108

NOMESCO Finland

Inhalation

3.6

50.6

167

464

A04

ICPC

Weakness/tiredness general

1.4

50.5

2569

18935

WZB00

NOMESCO Finland

Telephone prescription or other care instructions

1.3

49.9

4645

37470

A01

ICPC

Pain general/multiple sites

1.5

49.9

1606

10856

TNX10

NOMESCO Finland

Arthrocentesis, unspecified region, unspecified region

1.6

49.9

1136

7098

L01BC59

ATC

trifluridine, combinations; systemic

5.4

49.9

178

R55

ICD-10 Finland

Syncope and collapse

1.4

49.8

2127

15196

J44.1

ICD-10 Finland

Chronic obstructive pulmonary disease with acute exacerbation, unspecified

1.9

49.8

650

3466

PH2ST

NOMESCO Finland

Endovascular thrombolysis of pelvic and lower leg veins with radiological guidance

80.0

49.8

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

1.3

49.6

3398

26255

NF1AA

NOMESCO Finland

Hip X-ray examination

1.5

49.3

1691

11579

SPAT1211

SPAT

Application of soft bandage

1.5

49.2

1535

10306

XPX99

NOMESCO Finland

Other diagnostic examination of periferal vessel

1.6

49.2

1251

8027

J01EA01

ATC

trimethoprim; systemic

1.3

49.1

4721

38232

D70.82

ICD-10 Finland

Drug-induced neutropenia

2.5

48.7

310

1247

N02BF02

ATC

pregabalin; oral

1.7

48.4

950

5713

ZXA00

NOMESCO Finland

Right side

1.3

47.9

4963

40559

NB1AA

NOMESCO Finland

Shoulder X-ray examination without contrast

1.6

47.9

1263

8171

IAZ97

NOMESCO Finland

Psychiatric consultation in another specialty

2.9

47.9

223

765

WX722

NOMESCO Finland

PEEP

1.7

47.8

837

4879

TPW99

NOMESCO Finland

Other minor surgical procedure on peripheral vessel or lymphatic system

2.9

47.8

220

750

R5140

NOMESCO Finland

Monitoring the use of the aid

1.5

47.7

1885

13270

T81.0

ICD-10 Finland

Haemorrhage and haematoma complicating a procedure, not elsewhere classified

1.6

47.6

1103

6920

N06AA09

ATC

amitriptyline; systemic

1.5

47.6

1719

11893

B01AE07

ATC

dabigatran etexilate; oral

1.8

47.5

744

4200

GD1FN

NOMESCO Finland

Lung ventilation isotope imaging

14.3

47.3

R06.2

ICD-10 Finland

Wheezing

1.8

47.0

718

4022

J44.9

ICD-10 Finland

Chronic obstructive pulmonary disease, unspecified

1.7

46.9

892

5320

JN3CD

NOMESCO Finland

Abdominal CT examination both without and with contrast

1.9

46.7

628

3381

A07AA02

ATC

nystatin; oral

1.6

46.7

1088

6834

PH7ZT

NOMESCO Finland

Intravenous removal of filter to inferior vena cava

101.8

46.7

R03AL09

ATC

formoterol, glycopyrronium bromide and beclometasone; inhalant

2.0

46.6

540

2767

RT274, ,

NOMESCO Finland

8.0

46.5

L15

ICPC

Knee symptom/complaint

1.3

46.4

3998

31875

NA2AA

NOMESCO Finland

Thoracal spine X-ray examination without contrast

2.1

46.3

466

2271

F32.2

ICD-10 Finland

Severe depressive episode without psychotic symptoms

1.7

46.3

895

5361

202

Kela drug reimbursment

Connective tissue diseases, rheumatoid arthritis and comparable disease

1.4

46.3

1901

13478

N03AX14

ATC

levetiracetam; systemic

2.0

46.2

497

2481

N03AX09

ATC

lamotrigine; oral

1.9

45.9

636

3457

D50.0

ICD-10 Finland

Iron deficiency anaemia secondary to blood loss (chronic)

1.8

45.9

659

3623

WD305

NOMESCO Finland

Simple therapy of methastized malignancy with biomodifiers

2.6

45.8

261

996

N18.8

ICD-10 Finland

Other chronic renal failure

2.0

45.4

500

2518

N05AX12

ATC

aripiprazole; systemic

2.0

45.3

469

2309

GA1AE

NOMESCO Finland

Ultrasound examination of thorax

2.1

45.2

440

2117

TK800

NOMESCO Finland

Hemodialysis

2.2

45.1

392

1805

I82.21

ICD-10 Finland

Emboli and thrombosis in the inferior vena cava

12.1

45.0

K57.3

ICD-10 Finland

Diverticular disease of large intestine without perforation or abscess

1.3

44.9

3499

27498

R81

ICPC

Pneumonia

1.8

44.8

630

3440

WB121

NOMESCO Finland

Demanding neoadjuvant cytostatic therapy

2.8

44.8

225

804

PHD99

NOMESCO Finland

Resection of other vein

1.6

44.8

1030

6449

TQW11

NOMESCO Finland

Vacuum treatment of wound

2.2

44.8

385

1766

R42

ICD-10 Finland

Dizziness and giddiness

1.3

44.7

4292

34684

R03AC03

ATC

terbutaline; inhalant

1.4

44.7

2275

16747

123

Kela drug reimbursment

Chronic disorders of vitamin D metabolism

2.1

44.6

426

2036

JF1AB

NOMESCO Finland

Passage examination of small bowell with X-ray

2.4

44.5

309

1294

NA1AD

NOMESCO Finland

Cervical spine CT examination

1.7

44.5

790

4622

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

1.4

44.3

2177

15928

GA4AT

NOMESCO Finland

Cathetrisation of pleural cavity with ultrasound guidance

2.6

44.3

255

978

PHM76

NOMESCO Finland

Endovenous obliteration of v.saphena magna

1.9

44.2

585

3135

FM1DE

NOMESCO Finland

Doppler ultrasound examination of heart

1.5

44.0

1690

11826

R03DA04

ATC

theophylline; systemic, rectal

1.6

43.8

1035

6522

M01AE03

ATC

ketoprofen; systemic, rectal

1.2

43.8

6769

57852

JN5DR

NOMESCO Finland

PET-CT of upper body metabolism

2.5

43.3

277

1117

Z51.1

ICD-10 Finland

Chemotherapy session for neoplasm

2.5

43.2

263

1036

WW200

NOMESCO Finland

Immunization

2.0

42.9

456

2267

N30.9

ICD-10 Finland

Cystitis, unspecified

1.6

42.9

1109

7139

WB103

NOMESCO Finland

Simple adjuvant cytostatic therapy

1.9

42.7

584

3162

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

1.3

42.7

5099

42293

ZXE11

NOMESCO Finland

Procedure duration 60 to 89 minutes

1.7

42.7

814

4857

112

Kela drug reimbursment

Severe psychotic and other severe mental disorders

1.6

42.5

1087

6978

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

1.4

42.5

2073

15143

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

1.5

42.4

1640

11486

JN1CG

NOMESCO Finland

Extensive MRI examination of upper part of abdomen with high intensity magnet

2.1

42.3

423

2056

X69

ICD-10 Finland

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

2.0

42.2

449

2234

XX1XW

NOMESCO Finland

Extensive written report from radiologist

2.1

42.1

389

1835

R31

ICD-10 Finland

Unspecified haematuria

1.4

42.1

1919

13854

L01AX03

ATC

temozolomide; systemic

3.5

42.0

147

425

A04AD12

ATC

aprepitant; systemic

2.2

41.9

343

1542

A07AA09

ATC

vancomycin; oral

2.4

41.9

287

1195

L16

ICPC

Ankle symptom/complaint

1.4

41.9

1747

12410

WD325

NOMESCO Finland

Demanding therapy of methastized malignancy with biomodifiers

2.7

41.8

220

806

J45

ICD-10 Finland

Asthma

1.5

41.7

1630

11440

R06AE07

ATC

cetirizine; oral

1.2

41.7

7266

62808

E86

ICD-10 Finland

Volume depletion

1.9

41.6

501

2602

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

1.2

41.5

7056

60831

QBB10

NOMESCO Finland

Major dressing of wound of skin of trunk

1.8

41.3

585

3203

UJF45

NOMESCO Finland

Flexible sigmoidoscopy with biopsy

1.5

41.1

1489

10295

Y88.3

ICD-10 Finland

Sequelae of surgical and medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1.9

41.1

521

2752

D38.1

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Trachea, bronchus and lung

1.9

41.1

541

2893

A29

ICPC

General symptom/complaint other

1.4

41.1

2194

16267

FXA20

NOMESCO Finland

Total cardiopulmonary bypass in deep hypothermia and circulatory arrest at concurrent surgical procedure

9.6

41.0

XG470

NOMESCO Finland

Measurement of diffusion capastity of the lungs

1.9

40.8

487

2521

B03XA02

ATC

darbepoetin alfa; parenteral

2.1

40.7

385

1834

A11CC03

ATC

alfacalcidol; systemic

2.0

40.7

428

2121

J84.1

ICD-10 Finland

Other interstitial pulmonary diseases with fibrosis

2.1

40.6

384

1828

F32.10

ICD-10 Finland

Moderate depressive episode without somatic syndrome

1.6

40.6

1053

6781

XW000

NOMESCO Finland

Bone marrow biopsy

1.7

40.6

730

4287

SPAT1156

SPAT

Guidance concerning treatment of rash and skin

1.4

40.5

2476

18756

T84.0

ICD-10 Finland

Mechanical complication of internal joint prosthesis

1.7

40.3

682

3936

LC2BE

NOMESCO Finland

Transvaginal ultrasound examination of uterus, parametria and lower abdomen

1.3

40.3

3499

27861

SPAT1240

SPAT

Therapeutic discussion

1.5

40.1

1339

9107

L98.4

ICD-10 Finland

Chronic ulcer of skin, not elsewhere classified

2.1

40.0

399

1938

J01CA04

ATC

amoxicillin; systemic

1.2

40.0

14923

138959

N05CD07

ATC

temazepam; oral

1.4

39.8

2309

17345

M80.9

ICD-10 Finland

Unspecified osteoporosis with pathological fracture

2.1

39.8

391

1890

S81.8

ICD-10 Finland

Open wound of other parts of lower leg

1.8

39.7

597

3329

PHM77

NOMESCO Finland

Endovenous obliteration of v.saphena parva

2.8

39.7

204

739

HA1AA

NOMESCO Finland

X-ray mammography

1.5

39.6

1196

7968

ZXH04

NOMESCO Finland

Procedure performed in other inpatient unit

3.9

39.4

115

294

Z94.0

ICD-10 Finland

Kidney transplant status

2.8

39.4

199

714

KA1AE

NOMESCO Finland

Kidney ultrasound examination

2.0

39.4

449

2289

SPAT1260

SPAT

Consultation of another employee

1.3

39.4

3041

23825

R52.2

ICD-10 Finland

Other chronic pain

1.8

39.3

596

3331

PH7AC

NOMESCO Finland

Lumbal cavography with X-ray

57.4

39.2

AA1BD

NOMESCO Finland

Extensive CT of head and brain

1.9

39.1

465

2405

R4120

NOMESCO Finland

Occupational therapy

1.6

39.0

1053

6842

Y83.9

ICD-10 Finland

Surgical procedure, unspecified as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1.9

39.0

506

2695

AA1DG

NOMESCO Finland

Very extensive MRI examination of brain with high intensity magnet

1.9

38.5

459

2376

R18

ICD-10 Finland

Ascites

2.1

38.5

360

1708

M01AH02

ATC

rofecoxib; oral

1.4

38.5

2321

17535

RS221, ,

NOMESCO Finland

2.5

38.2

247

1002

L04AD01

ATC

ciclosporin; systemic

2.3

38.1

298

1316

WYA30

NOMESCO Finland

Treatment of a patient needing special arrangements

1.5

38.0

1222

8249

E11.9

ICD-10 Finland

Type 2 diabetes mellitus, without complications

1.3

37.9

4562

37778

A41.8

ICD-10 Finland

Other specified sepsis

2.1

37.8

353

1673

A41.0

ICD-10 Finland

Sepsis due to Staphylococcus aureus

2.1

37.8

381

1859

AAB10

NOMESCO Finland

Partial excision of intracranial lesion

2.9

37.7

180

627

K92.1

ICD-10 Finland

Melaena

1.6

37.6

992

6413

WX730

NOMESCO Finland

Conventional respirator

2.3

37.4

294

1300

R5110, ,

SPAT

1.5

37.4

1164

7801

K29

ICPC

Cardiovascular sympt/complt other

1.6

37.3

804

4953

R10.0

ICD-10 Finland

Acute abdomen

1.8

37.1

528

2895

SPAT1306

SPAT

Counselling and guidance related to nutrition and weight management

1.4

37.1

2288

17338

Z71.8

ICD-10 Finland

Other specified counselling

1.2

37.1

4870

40719

R2130

NOMESCO Finland

Counselling and guidance which enhance independent living

1.5

37.1

1369

9498

I81

ICD-10 Finland

Portal vein thrombosis

4.1

37.1

102

250

NGB20

NOMESCO Finland

Primary total prosthetic replacement of knee joint without patellar part

1.4

37.0

1984

14705

ZXM10

NOMESCO Finland

Intraoperative use of conventional X-ray imaging

1.6

37.0

1016

6628

C34.12

ICD-10 Finland

Malignant tumor of the anterior, bronchial or pulmonary adenocarcinoma

2.4

36.9

249

1030

U07.1

ICD-10 Finland

Emergency use of U07.1 | COVID-19, virus identified

1.3

36.9

2675

20758

ZX012

NOMESCO Finland

Radiotherapy with large shaped fields - isocentric therapy

1.6

36.8

959

6180

L04AD02

ATC

tacrolimus; systemic

2.9

36.7

169

577

Z03.5

ICD-10 Finland

Observation for other suspected cardiovascular diseases

1.5

36.7

1262

8633

R03AK04

ATC

salbutamol and sodium cromoglicate; inhalant

2.7

36.6

197

731

M80.4

ICD-10 Finland

Drug-induced osteoporosis with pathological fracture

3.7

36.6

115

310

M03BX02

ATC

tizanidine; oral

1.2

36.6

10549

95354

XQ858

NOMESCO Finland

Oxygen partial pressure measurement

2.6

36.5

214

829

M17.9

ICD-10 Finland

Gonarthrosis, unspecified

1.4

36.4

2146

16144

JAD30

NOMESCO Finland

Repair of incisional hernia using prosthetic material

2.2

36.4

320

1482

KBV02

NOMESCO Finland

Cystoscopic insertion of stent into ureter

2.0

36.3

403

2037

Z49.1

ICD-10 Finland

Extracorporeal dialysis

2.4

36.2

245

1015

SPAT1125

SPAT

Stoma care and guidance

2.1

36.2

338

1603

S06.0

ICD-10 Finland

Concussion

1.4

36.1

1738

12651

TPX15

NOMESCO Finland

Removal of vascular injection port

3.8

36.0

111

295

N19

ICD-10 Finland

Unspecified kidney failure

1.7

35.8

678

4038

EP1AE

NOMESCO Finland

Neck ultrasound examination

1.6

35.7

917

5892

R03AC13

ATC

formoterol; inhalant

1.6

35.7

849

5358

QDB05

NOMESCO Finland

Revision of wound of skin of lower limb

1.9

35.7

469

2509

F33.2

ICD-10 Finland

Recurrent depressive disorder, current episode severe without psychotic symptoms

1.8

35.6

591

3394

L01CA04

ATC

vinorelbine; systemic

2.8

35.6

182

658

KH1BT

NOMESCO Finland

Urinary tract cathetrisation with X-ray guidance

2.5

35.5

219

870

N06AX21

ATC

duloxetine; oral

1.4

35.5

1787

13107

N06AB10

ATC

escitalopram; oral

1.3

35.5

2915

23003

M25.5

ICD-10 Finland

Pain in joint

1.2

35.4

5017

42256

C03EA01

ATC

hydrochlorothiazide and potassium-sparing agents; oral

1.3

35.4

2972

23515

JA3AT

NOMESCO Finland

Cathetrisation of abdominal cavity with ultrasound guidance

2.2

35.3

309

1428

M48.0

ICD-10 Finland

Spinal stenosis

1.3

35.3

2282

17407

GD1CT

NOMESCO Finland

Biopsy of the lung with CT guidance

2.3

35.1

272

1197

J84.8

ICD-10 Finland

Other specified interstitial pulmonary diseases

2.4

35.1

233

958

WX000

NOMESCO Finland

Monitoring vital functions without anesthesy

1.7

35.0

636

3744

C03EB01

ATC

furosemide and potassium-sparing agents; systemic

1.6

35.0

813

5099

ZXE40

NOMESCO Finland

More than seven and less than nine hours

2.0

34.9

394

2003

E11.8

ICD-10 Finland

Type 2 diabetes mellitus, with unspecified complications

1.4

34.7

1920

14295

AA1CD

NOMESCO Finland

Very extensive CT of head and brain

2.2

34.7

308

1432

J09

ICD-10 Finland

Influenza due to identified zoonotic or pandemic influenza virus

1.9

34.6

459

2462

S32.0

ICD-10 Finland

Fracture of lumbar vertebra

1.7

34.5

586

3387

WD135

NOMESCO Finland

Demanding cystostatic therapy of methastized malignancy

2.9

34.5

165

576

WX320

NOMESCO Finland

Spinalanesthesy

1.3

34.4

4229

35048

R06.4

ICD-10 Finland

Hyperventilation

2.3

34.4

255

1101

S76

ICPC

Skin infection other

1.6

34.3

870

5571

C56

ICD-10 Finland

Malignant neoplasm of ovary

3.3

34.3

128

386

SPAT1217

SPAT

Assessment of need for services (elderly/care support)

1.4

34.3

1460

10397

SPAT1251

SPAT

Organisation of medication

1.7

34.3

638

3781

M01AX17

ATC

nimesulide; oral

1.2

34.2

4307

35787

ZXE02

NOMESCO Finland

Procedure duration 10 to 19 minutes

1.6

34.2

743

4585

Z76.8

ICD-10 Finland

Persons encountering health services in other specified circumstances

1.7

34.1

645

3839

C56.71

ICD-10 Finland

Serous epithelial malignant tumor of the ovary

2.9

34.1

165

579

NF3AA

NOMESCO Finland

Femur X-ray examination

2.0

34.1

392

2005

S22.3

ICD-10 Finland

Fracture of rib

1.5

34.0

1194

8198

M03BC01

ATC

orphenadrine (citrate); systemic

1.3

34.0

3393

27434

A02BC03

ATC

lansoprazole; oral

1.2

33.9

5169

43839

C90.0

ICD-10 Finland

Multiple myeloma

2.4

33.5

222

912

SPAT1104

SPAT

Monitoring of emergency patient

1.5

33.5

1119

7610

I28.9

ICD-10 Finland

Disease of pulmonary vessels, unspecified

10.0

33.4

45000, ,

ICD-8 Finland

+∞

33.3

XX1AT

NOMESCO Finland

Other puncture with ultrasound guidance

2.4

33.3

221

909

J01CE08

ATC

benzathine benzylpenicillin; parenteral

2.4

33.2

220

904

138

Kela drug reimbursment

Severe anaemia associated with chronic renal failure

1.9

33.1

393

2034

SPAT1231

SPAT

Assessment of adjustments needed in living environment

2.0

33.0

368

1864

E66

ICD-10 Finland

Obesity

1.7

32.9

667

4044

I83.2

ICD-10 Finland

Varicose veins of lower extremities with both ulcer and inflammation

2.8

32.7

159

560

111

Kela drug reimbursment

Epilepsy and comparable convulsive disorders

1.6

32.7

829

5311

L89

ICD-10 Finland

Decubitus ulcer and pressure area

2.0

32.6

360

1816

M79.1

ICD-10 Finland

Myalgia

1.3

32.6

2129

16253

J01CA08

ATC

pivmecillinam; oral

1.2

32.5

6598

57515

I10

ICD-10 Finland

Essential (primary) hypertension

1.2

32.5

12081

111152

R07.1

ICD-10 Finland

Chest pain on breathing

2.2

32.4

260

1161

SPAT1256

SPAT

Intramuscular and subcutaneous injection

1.2

32.4

7312

64370

J22

ICD-10 Finland

Unspecified acute lower respiratory infection

1.6

32.4

886

5773

A03

ICPC

Fever

1.3

32.3

2253

17363

R03AL06

ATC

olodaterol and tiotropium bromide; inhalant

2.0

32.3

338

1673

SPAT1245

SPAT

Provision of support and information to patient’s family members

1.6

32.2

815

5216

A41.1

ICD-10 Finland

Sepsis due to other specified staphylococcus

3.1

32.2

134

432

HA1AE

NOMESCO Finland

Ultrasound examination of mammary glands

1.5

32.2

985

6575

R96

ICPC

Asthma

1.4

32.2

1508

10918

ZXM00

NOMESCO Finland

Intraoperative use of ultrasonographic imaging

2.7

32.2

177

665

KAS10

NOMESCO Finland

Allogenic transplantation of kidney from cadaver donor

2.9

32.1

153

533

J01EE02

ATC

sulfadiazine and trimethoprim; systemic

1.2

32.1

4227

35266

S80.0

ICD-10 Finland

Contusion of knee

1.5

32.1

1059

7183

N03AE01

ATC

clonazepam; systemic

1.5

32.0

913

6005

E87.6

ICD-10 Finland

Hypokalaemia

1.7

31.7

579

3414

F33.9

ICD-10 Finland

Recurrent depressive disorder, unspecified

1.8

31.6

511

2914

SPAT1234

SPAT

Support of social functional capacity

1.5

31.5

945

6281

F33.10

ICD-10 Finland

Recurrent depression, moderate episode without somatic syndrome

1.7

31.5

648

3944

JJ2AT

NOMESCO Finland

Biopsy of liver with ultrasound guidance

2.0

31.3

355

1808

ZX112

NOMESCO Finland

Subcutaneous

2.0

31.3

361

1850

R03AK03

ATC

[U] fenoterol and ipratropium bromide

1.5

31.2

1013

6848

WVA20

NOMESCO Finland

Medicine administration

1.9

31.1

423

2288

XF622

NOMESCO Finland

Measurement of minute volume of heart

4.3

31.0

187

TPH40

NOMESCO Finland

Insertion of a long peripheral venous catheter

3.2

31.0

125

396

L03.1

ICD-10 Finland

Cellulitis of other parts of limb

1.8

31.0

475

2666

UJF30

NOMESCO Finland

Ileoscopy through colon

1.4

30.9

1617

11924

NA7DG

NOMESCO Finland

Spine and spinal cord very extensive MRI examination with high intensity magnet

2.5

30.9

192

766

NK4XE

NOMESCO Finland

Joint ultrasound examination not elsewhere classified

1.5

30.9

980

6593

J01FA10

ATC

azithromycin; systemic

1.2

30.8

9230

83198

JAL20

NOMESCO Finland

Excision or destruction of lesion of peritoneum

3.8

30.7

240

LX1AE

NOMESCO Finland

Gynecological ultrasound examination as part of clinical examination

1.4

30.7

1210

8494

C20

ICD-10 Finland

Malignant neoplasm of rectum

2.6

30.7

183

716

F45.4

ICD-10 Finland

Persistent somatoform pain disorder

2.2

30.7

257

1169

N39.4

ICD-10 Finland

Other specified urinary incontinence

1.4

30.6

1542

11299

Z94.8

ICD-10 Finland

Other transplanted organ and tissue status

3.9

30.4

233

M23.2

ICD-10 Finland

Derangement of meniscus due to old tear or injury

1.4

30.4

1794

13484

ZY010

NOMESCO Finland

Hospital outpatient

1.7

30.3

628

3831

R03BA01

ATC

beclometasone; inhalant

1.3

30.3

2319

18098

ZY000

NOMESCO Finland

Hospital inpatient

2.6

30.2

172

658

8140/3-C34.1

ICD-O-3

Adenocarcinoma, NOS, of upper lobe, lung

3.0

30.1

135

455

R05

ICD-10 Finland

Cough

1.3

30.0

3429

28127

JAH01

NOMESCO Finland

Laparoscopy

1.6

29.9

631

3865

B99

ICD-10 Finland

Other and unspecified infectious diseases

2.0

29.9

344

1762

AA1BG

NOMESCO Finland

Standard MRI examination of brain with high intensity magnet

1.4

29.9

1306

9341

M05BA04

ATC

alendronic acid; oral

1.4

29.9

1609

11920

R05DA20

ATC

opium alkaloids and derivatives - combinations

1.2

29.8

4191

35172

R33

ICD-10 Finland

Retention of urine

1.4

29.7

1476

10789

L02BA03

ATC

fulvestrant; parenteral

3.0

29.6

127

417

KH1FT

NOMESCO Finland

Exchange of urinary catheter with radiological guidance

3.2

29.6

115

356

M51.1

ICD-10 Finland

Lumbar and other intervertebral disc disorders with radiculopathy

1.3

29.6

2241

17456

PH7UT

NOMESCO Finland

Removal of thrombosis from vein of lower extremity or pelvis or from vena cava inferior

154.6

29.6

QX3HE

NOMESCO Finland

Ultrsound examination of lesion close to skin

2.2

29.6

256

1180

E27.3

ICD-10 Finland

Drug-induced adrenocortical insufficiency

3.6

29.5

270

ZZA00

NOMESCO Finland

Split skin graft

1.7

29.5

493

2837

PH9AT

NOMESCO Finland

Expansion (PTA) of vein not elsewhere classified

44.8

29.5

L04AX03

ATC

methotrexate; systemic

1.4

29.5

1466

10717

TJF80

NOMESCO Finland

Ostomy education

2.4

29.4

195

802

L02.4

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle of limb

1.7

29.3

508

2954

D43.0

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Brain, supratentorial

3.1

29.2

124

405

L03AA14

ATC

lipegfilgrastim; parenteral

2.1

29.2

293

1429

A12AA04

ATC

calcium carbonate; oral

2.1

29.2

272

1290

GD5AD

NOMESCO Finland

Thorax and upper abdomen combined CT examination of

2.2

29.1

252

1161

M02AA07

ATC

piroxicam; topical

1.2

29.1

6534

57348

D68.3

ICD-10 Finland

Haemorrhagic disorder due to circulating anticoagulants

3.5

29.1

100

287

N06AX12

ATC

bupropion; oral

1.6

29.0

777

5039

R29.8

ICD-10 Finland

Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems

1.4

29.0

1317

9481

C34.82

ICD-10 Finland

Malignant overall tumor of bronchial and pulmonary adenocarcinoma

3.3

29.0

111

341

N07BC02

ATC

methadone; systemic

4.1

28.9

189

M10.0

ICD-10 Finland

Idiopathic gout

1.7

28.7

592

3607

F10.1

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Harmful use

1.5

28.6

966

6580

Z53.2

ICD-10 Finland

Procedure not carried out because of patient's decision for other and unspecified reasons

2.3

28.6

209

898

155

Kela drug reimbursment

Afatinib and gefitinib

6.1

28.5

D62

ICD-10 Finland

Acute posthaemorrhagic anaemia

2.4

28.5

195

814

NGF25

NOMESCO Finland

Operation for osteochondritis of knee, arthroscopic

1.5

28.5

1003

6890

-50

ICPC

Medication/prescr/renewal

1.6

28.5

683

4319

SPAT1172

SPAT

Guidance concerning hydration

1.8

28.4

455

2589

J01CE02

ATC

phenoxymethylpenicillin; oral

1.2

28.3

11650

107485

R03AC12

ATC

salmeterol; inhalant

1.5

28.3

783

5117

L01BA01

ATC

methotrexate; systemic

1.7

28.3

584

3560

N03AG01

ATC

valproic acid; systemic, rectal

1.5

28.2

864

5768

JMA10

NOMESCO Finland

Transabdominal total splenectomy

3.1

28.2

115

367

R23.3

ICD-10 Finland

Spontaneous ecchymoses

1.9

28.1

356

1883

N02AA01

ATC

morphine; systemic, rectal

2.0

28.1

326

1675

R05FB02

ATC

cough suppressants and expectorants; systemic

1.2

28.0

6626

58369

WX721

NOMESCO Finland

Oxygen concentrator therapy

4.5

27.9

148

KA2AE

NOMESCO Finland

Ultrasound examination transplanted kidney

3.0

27.7

125

423

JN1DG

NOMESCO Finland

Very extensive MRI examination of upper part of abdomen with high intensity magnet

2.0

27.7

289

1431

SPAT1167

SPAT

Insertion of urinary catheter

1.6

27.6

591

3636

182

Kela drug reimbursment

Brivaracetam, eslikarbazepin, gabapentin, lacosamide, levetiracetam, perampanel, pregabalin, tiagabin and zonisamide

1.9

27.6

328

1700

190

Kela drug reimbursment

Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide

2.7

27.5

151

567

L04AA01

ATC

[U] ciclosporin

2.2

27.5

231

1052

AAG50

NOMESCO Finland

Stereotactic intracranial radiotherapy

3.2

27.4

105

323

R05FA02

ATC

opium derivatives and expectorants; systemic

1.2

27.4

6794

60070

P01BA02

ATC

hydroxychloroquine; oral

1.4

27.4

1266

9142

K56.7

ICD-10 Finland

Ileus, unspecified

2.0

27.3

307

1561

K59.09

ICD-10 Finland

Constipation, unspecified

1.4

27.3

1135

8045

A02BA02

ATC

ranitidine; systemic

1.2

27.3

3446

28556

G04BE03

ATC

sildenafil; oral

2.1

27.2

247

1160

T84.5

ICD-10 Finland

Infection and inflammatory reaction due to internal joint prosthesis

2.0

27.2

275

1345

M13.9

ICD-10 Finland

Arthritis, unspecified

1.4

27.2

1132

8023

ZXE01

NOMESCO Finland

Procedure duration 0 to 9 minutes

2.1

27.1

241

1124

ZX121

NOMESCO Finland

Central venous catheter

3.8

27.0

212

WF002

NOMESCO Finland

Radical radiotherapy

1.5

26.9

888

6023

J96.9

ICD-10 Finland

Respiratory failure, unspecified

2.8

26.8

137

496

I63.9

ICD-10 Finland

Cerebral infarction, unspecified

1.3

26.8

1958

15167

R04.0

ICD-10 Finland

Epistaxis

1.4

26.8

1313

9575

J20

ICD-10 Finland

Acute bronchitis

1.4

26.7

1551

11619

8140/3-C34.3

ICD-O-3

Adenocarcinoma, NOS, of lower lobe, lung

3.4

26.7

279

R28

ICPC

Limited function/disability (R)

2.2

26.7

234

1085

N05AX08

ATC

risperidone; systemic

1.4

26.7

1420

10495

I70.2

ICD-10 Finland

Atherosclerosis of arteries of extremities

1.3

26.6

1693

12858

WX740

NOMESCO Finland

Nitrogen oxide therapy

4.8

26.6

126

M05.8

ICD-10 Finland

Other seropositive rheumatoid arthritis

1.5

26.6

855

5768

C20.91

ICD-10 Finland

Malignant tumor of the rectum invasive carcinoma

1.8

26.6

406

2278

Z3229

NOMESCO Finland

Other healthcare associate professional

1.4

26.6

1410

10416

JFB00

NOMESCO Finland

Partial resection of small intestine

2.0

26.5

281

1400

SPAT1250

SPAT

Comprehensive monitoring of chronic illness

1.2

26.4

4843

41649

F32.3

ICD-10 Finland

Severe depressive episode with psychotic symptoms

2.0

26.3

272

1343

N03AF02

ATC

oxcarbazepine; oral

1.7

26.3

481

2841

R56.8

ICD-10 Finland

Other and unspecified convulsions

1.5

26.3

720

4695

EBA15

NOMESCO Finland

Extraction of multiple teeth

1.6

26.2

620

3908

PBL10

NOMESCO Finland

Construction of arteriovenous fistula from radial artery

2.3

26.2

188

802

N05AF03

ATC

chlorprothixene; systemic

1.8

26.2

358

1942

K56.5

ICD-10 Finland

Intestinal adhesions [bands] with obstruction

1.9

26.1

314

1633

P76

ICPC

Depressive disorder

1.5

26.1

747

4917

J01CF05

ATC

flucloxacillin; systemic

1.5

26.1

897

6134

ND2AA

NOMESCO Finland

Hand and fingers X-ray examination

1.4

26.0

1351

9943

45003

ICD-8 Finland

Pulmonary embolism and infarction, Thrombosis

+∞

26.0

45099, ,

ICD-8 Finland

+∞

26.0

D37.7

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Other digestive organs

1.7

26.0

439

2536

JFF10

NOMESCO Finland

Loop enterostomy

3.0

25.8

115

387

OAB73

NOMESCO Finland

Prevention and treatment of malnutrition

2.7

25.8

142

535

C08CA01

ATC

amlodipine; oral

1.2

25.8

7270

64880

A79

ICPC

Malignancy NOS

2.0

25.7

272

1353

M70.6

ICD-10 Finland

Trochanteric bursitis

1.3

25.7

2100

16514

K28

ICPC

Limited function/disability (K)

1.8

25.6

399

2252

C71.13

ICD-10 Finland

Malignant tumor of frontal lobe grade IV glioma

6.1

25.6

J01.0

ICD-10 Finland

Acute maxillary sinusitis

1.2

25.6

3313

27506

XW4AT

NOMESCO Finland

Biopsy of other inner organ with ultrasound guidance

3.4

25.5

258

N06AB03

ATC

fluoxetine; oral

1.3

25.5

1811

13971

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

1.4

25.5

1144

8218

M66.0

ICD-10 Finland

Rupture of popliteal cyst

2.1

25.5

233

1099

J01DA09

ATC

[U] cefadroxil

1.2

25.4

4212

35850

L04AX04

ATC

lenalidomide; oral

3.0

25.4

114

385

N02BF01

ATC

gabapentin; oral

1.4

25.4

1229

8941

T88.7

ICD-10 Finland

Unspecified adverse effect of drug or medicament

2.0

25.3

256

1253

JKA20

NOMESCO Finland

Cholecystectomy

1.7

25.3

466

2756

ZXE13

NOMESCO Finland

Procedure duration 90 to 119 minutes

1.7

25.3

425

2451

Z50.1

ICD-10 Finland

Other physical therapy

1.5

25.3

856

5833

KBV00

NOMESCO Finland

Insertion of stent into ureter

2.8

25.3

125

445

ZX070

NOMESCO Finland

Intensity modified radiotherapy

1.9

25.3

296

1527

J01XX08

ATC

linezolid; systemic

2.8

25.2

122

430

M09AX01

ATC

hyaluronic acid; parenteral

1.5

25.2

867

5930

M71.2

ICD-10 Finland

Synovial cyst of popliteal space [Baker]

1.6

25.2

542

3340

Z35.8

ICD-10 Finland

Supervision of other high-risk pregnancies

1.6

25.2

564

3510

SPAT1252

SPAT

Overall medication plan or its review

1.4

25.1

1189

8619

153

Kela drug reimbursment

Lenalidomid

2.9

25.1

117

404

L03.9

ICD-10 Finland

Cellulitis, unspecified

1.9

25.1

329

1762

SPAT1215

SPAT

Assessment of need for medical rehabilitation

1.6

25.0

630

4030

S80.1

ICD-10 Finland

Contusion of other and unspecified parts of lower leg

1.7

25.0

481

2880

192

Kela drug reimbursment

Fulvestrant

3.1

24.9

104

337

SPAT1109

SPAT

Analgesia with portable analgesic pump

2.8

24.9

127

460

R03AK11

ATC

formoterol and fluticasone; inhalant

1.8

24.9

367

2038

M01AH01

ATC

celecoxib; oral

1.2

24.9

3013

24826

JN6AD

NOMESCO Finland

CT of torso and neck

2.0

24.8

261

1296

L03

ICPC

Low back symptom/complaint

1.2

24.8

4304

36781

S82.8

ICD-10 Finland

Fractures of other parts of lower leg

1.6

24.8

574

3599

3012

Kela drug reimbursment

Cabozantinib

4.7

24.7

122

FM1BE

NOMESCO Finland

Cardiac ultrasound examination through oesophagus

1.4

24.7

1023

7244

T81.3

ICD-10 Finland

Disruption of operation wound, not elsewhere classified

1.8

24.7

367

2043

I15.1

ICD-10 Finland

Hypertension secondary to other renal disorders

2.4

24.7

175

743

ZXD30

NOMESCO Finland

Difficulties in perfomrming procedure

1.6

24.7

637

4099

K42.9

ICD-10 Finland

Umbilical hernia without obstruction or gangrene

1.5

24.6

738

4905

A12BA01

ATC

potassium chloride; oral

1.5

24.6

849

5809

G44.2

ICD-10 Finland

Tension-type headache

1.3

24.6

1939

15170

TNX33

NOMESCO Finland

Custom moulded cast, unspecified region

1.5

24.6

766

5134

N17.8

ICD-10 Finland

Other acute renal failure

2.2

24.5

216

1004

O22.8

ICD-10 Finland

Other venous complications in pregnancy

31.9

24.5

E66.0

ICD-10 Finland

Obesity due to excess calories

2.3

24.5

178

764

W00

ICD-10 Finland

Fall on same level involving ice and snow

1.3

24.4

1729

13331

L02BG06

ATC

exemestane; oral

2.0

24.4

262

1312

G03FA14

ATC

dydrogesterone and estrogen; systemic

0.6

24.4

315

5626

Z02.7

ICD-10 Finland

Issue of medical certificate

1.4

24.3

1097

7884

JA2AT

NOMESCO Finland

Abdominal puncture with ultrasound guidance

2.4

24.3

164

681

M17.3

ICD-10 Finland

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3042936) Bacteria identified in Isolate by Culture

4356

24401

1.98

312.90

2.3

2.0

—

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

5713

35106

1.85

308.79

4.8

3.9

235.90

496.38

ng/l

6.17

4759

28600

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

363

381

9.63

308.05

1.1

—

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

2905

3828

8.60

307.65

2.4

2.1

96.27

88.89

43.88

2718

3699

(3012095) Magnesium [Moles/volume] in Serum or Plasma

5316

28353

2.16

307.65

4.6

3.1

0.81

0.82

mmol/l

10.58

5040

26220

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

1791

1506

12.84

307.65

1.3

1.2

3.81

3.94

u/ml

0.13

784

691

(3036489) Thrombin time

3049

5075

6.82

307.65

2.3

1.9

21.62

21.66

0.08

2409

4567

(3003396) Base excess in Arterial blood by calculation

4365

20562

2.40

307.65

8.2

6.8

1.28

1.06

mmol/l

3.25

3548

16315

(3013826) Glucose [Moles/volume] in Serum or Plasma

13618

102477

1.90

307.65

7.2

4.6

6.79

6.81

mmol/l

0.52

13102

96121

(3019198) Lymphocytes [#/volume] in Blood

11958

85546

1.90

307.65

7.7

5.7

1.82

1.91

e9/l

4.67

10585

74854

(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay

1509

988

16.29

307.65

1.2

1.1

95.38

96.07

0.28

1382

933

(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum

453

528

8.71

307.65

1.2

1.1

24.03

10.94

u/ml

0.49

(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay

619

410

15.45

307.65

1.1

1.0

98.15

96.96

0.27

493

321

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

2037

1328

16.79

307.65

1.1

119.25

117.48

0.92

1802

1201

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

705

549

13.19

307.65

1.3

1.2

—

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

1742

4200

4.41

307.65

3.3

2.3

3.68

3.62

g/l

0.91

1660

3986

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

3968

20137

2.18

307.65

2.1

1.8

—

(3002173) Hemoglobin [Mass/volume] in Arterial blood

3504

16880

2.28

307.65

9.2

7.5

121.26

120.66

g/l

0.90

3414

16412

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

712

614

11.91

307.65

1.2

1.1

1.09

1.06

ratio

2.04

237

216

(3006504) Eosinophils/100 leukocytes in Blood

11171

78241

1.89

307.65

8.0

5.9

2.67

2.87

16.37

10578

72480

(46235689) Lupus anticoagulant aPTT, dRVVT and PT screening panel W Reflex

1242

1025

12.75

307.65

2.4

2.2

—

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

12477

89115

1.96

307.65

9.9

6.5

1.21

mmol/l

12.65

10659

75150

(3002030) Lymphocytes/100 leukocytes in Blood

11382

80487

1.88

307.65

8.1

6.0

25.43

27.06

43.72

10811

74852

(3027801) Oxygen [Partial pressure] in Arterial blood

4369

20542

2.41

307.65

8.1

6.8

11.38

12.23

kpa

23.61

4151

19512

(3016502) Oxygen saturation in Arterial blood

3913

18413

2.37

307.65

8.5

7.1

95.00

95.61

7.10

3770

17696

(3018010) Neutrophils/100 leukocytes in Blood

11170

79213

1.85

307.65

7.7

5.8

59.30

57.85

28.89

10600

73608

(3024561) Albumin [Mass/volume] in Serum or Plasma

10878

77292

1.82

307.65

7.0

4.6

33.60

35.14

g/l

133.93

10216

71248

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

9179

54298

2.20

307.65

3.6

3.0

1457.83

1643.49

ng/l

3.02

8130

46562

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

2998

5502

6.15

307.65

3.7

2.7

0.38

0.34

u/ml

7.76

1974

3011

(3001604) Monocytes [#/volume] in Blood

11749

83303

1.91

307.65

7.6

5.6

0.62

0.60

e9/l

3.70

10195

71328

(3019069) Monocytes/100 leukocytes in Blood

11224

78668

1.89

307.65

8.3

6.2

8.69

8.72

0.41

10639

73001

(3019060) Gas panel - Arterial blood

2698

11969

2.43

307.65

5.4

4.6

—

(3033658) Prothrombin time (PT) actual/Normal

7429

43548

2.07

307.65

5.4

3.8

85.70

88.11

10.95

7163

42495

(3018677) aPTT in Platelet poor plasma by Coagulation assay

5057

27267

2.11

307.65

3.2

1.9

30.71

29.87

11.58

4926

26435

(3013650) Neutrophils [#/volume] in Blood by Automated count

13236

96659

1.97

307.65

13.9

8.7

4.35

4.20

e9/l

8.23

11771

83652

(3023368) Bacteria identified in Blood by Culture

8897

49406

2.37

307.65

5.7

4.2

—

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

4372

20554

2.41

307.65

8.2

6.8

5.06

5.08

kpa

0.53

4169

19528

(3022096) Basophils/100 leukocytes in Blood

10912

75832

1.89

307.65

7.9

5.9

0.63

0.67

12.89

10322

70123

(40760892) CBC W Ordered Manual Differential panel - Blood

11172

78318

1.89

307.65

8.6

6.2

—

(3034426) Prothrombin time (PT)

394

364

10.96

307.65

1.2

—

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

5624

29258

2.24

307.65

2.3

1.8

—

(3013115) Eosinophils [#/volume] in Blood

12006

86264

1.89

307.65

8.0

5.8

0.19

0.20

e9/l

7.86

10550

74813

(3006315) Basophils [#/volume] in Blood

11773

83553

1.90

307.65

7.6

5.6

0.04

e9/l

0.52

10210

71515

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

9384

34555

4.05

307.65

2.5

1.6

2.19

1.19

mg/l

72.77

7726

26515

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

12826

90458

2.04

307.65

9.6

5.9

10.94

11.75

umol/l

12.28

12355

85547

(3022217) INR in Platelet poor plasma by Coagulation assay

13889

84652

2.83

307.65

26.5

16.0

1.40

1.31

inr

13.93

4108

23800

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

2024

1403

15.77

307.65

1.1

—

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

2377

3613

7.25

307.65

2.8

2.3

202.00

195.09

2.59

2203

3434

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

3905

20735

2.07

307.65

4.7

4.0

254.11

245.05

u/l

2.81

3724

19461

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

1884

1534

13.32

307.65

1.3

1.2

3.68

4.29

u/ml

0.36

600

556

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

3990

20118

2.20

307.65

2.1

1.7

—

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

11595

80815

1.94

307.65

8.8

5.8

1.21

mmol/l

16.41

10835

73022

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

9965

68589

1.84

307.65

5.0

3.8

56.48

72.63

ng/l

0.40

7802

49476

(3018418) pH of Serum or Plasma

7817

52942

1.74

302.50

5.6

4.0

7.40

0.61

1814

9793

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

16051

132648

1.84

301.72

12.3

7.3

82.36

79.39

u/l

10.64

15429

124378

(3003458) Phosphate [Moles/volume] in Serum or Plasma

4123

23104

1.96

293.68

7.0

5.5

1.03

1.04

mmol/l

0.38

3856

21255

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

4324

24719

1.93

289.88

2.9

2.6

20.60

22.17

10.38

3727

20831

(3004789) Transferrin [Mass/volume] in Serum or Plasma

4524

26265

1.91

289.37

2.8

2.5

2.28

2.30

g/l

1.79

4231

24085

(3022948) Iron [Moles/volume] in Serum or Plasma

4787

28364

1.88

287.21

2.9

2.5

11.61

12.64

umol/l

19.53

4487

26165

(3020779) Urea [Moles/volume] in Serum or Plasma

3109

15881

2.11

285.59

8.4

6.8

10.34

10.54

mmol/l

0.78

2935

15012

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

337

368

9.25

277.54

1.1

—

(3014111) Lactate [Moles/volume] in Serum or Plasma

3056

15742

2.09

273.63

8.3

6.4

1.38

mmol/l

0.10

2971

15270

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

7850

54628

1.68

265.78

3.3

2.5

71.99

62.30

u/l

0.36

7378

50138

(3008152) Bicarbonate [Moles/volume] in Arterial blood

2393

11359

2.24

263.38

8.1

6.8

24.78

24.57

mmol/l

2.07

2285

10804

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

2234

10333

2.29

261.61

8.1

6.6

24.83

24.81

mmol/l

0.09

2214

10223

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

2646

13142

2.15

259.75

1.9

1.6

—

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

2070

9362

2.33

255.21

9.9

8.7

24.51

24.30

mmol/l

2.24

1983

8981

(3002582) Erythrocytes [#/volume] in Urine

7707

53934

1.66

251.77

4.4

3.3

113.71

98.67

e6/l

0.35

6132

41428

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

2331

11146

2.22

251.34

4.5

3.5

5.17

5.15

kpa

0.45

2216

10474

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

1734

7302

2.49

250.59

2.3

1.9

2.79

2.25

ug/l

0.27

1534

6382

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

2246

10603

2.24

249.83

4.4

3.4

2.08

1.80

mmol/l

2.86

1715

7838

(3009343) pH of Capillary blood

2304

10994

2.22

249.62

4.5

3.5

7.42

0.63

394

1394

(3000991) Gas panel - Venous blood

2857

14870

2.05

246.87

9.7

7.7

—

(3044640) Blood type and Crossmatch panel - Blood

7754

54756

1.65

241.91

3.1

2.4

—

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

3407

19042

1.93

239.51

5.0

3.8

37.47

23.65

ug/l

1.47

2850

15612

(3030467) Casts [#/volume] in Urine by Automated count

7133

49477

1.66

237.80

4.2

3.2

0.57

0.45

e6/l

2.23

5652

37814

(3026008) Bacteria identified in Urine by Culture

7857

56077

1.63

232.33

4.0

3.3

—

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

10405

79565

1.59

229.84

3.3

2.6

—

(3021447) Carbon dioxide [Partial pressure] in Venous blood

3065

16767

1.96

228.70

4.5

3.7

5.88

5.82

kpa

2.52

2965

16252

(3014007) Fractional oxyhemoglobin in Arterial blood

2283

11241

2.15

227.42

10.3

8.5

93.30

93.92

4.76

2275

11196

(3018095) Leukocytes [#/volume] in Urine

8500

62117

1.60

226.28

5.1

3.7

120.32

108.52

e6/l

0.45

6419

44456

(3002032) Base excess in Venous blood by calculation

3052

16755

1.95

225.09

4.6

3.7

2.13

1.90

mmol/l

2.73

2613

14215

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

6566

45166

1.65

222.89

2.6

2.3

3.38

3.01

mg/l

18.95

5706

38217

(3031040) Bacteria [#/volume] in Urine by Automated count

13897

114257

1.61

221.84

6.3

4.7

1344.47

1444.75

e6/l

0.09

246

1725

(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood

2269

11266

2.13

220.82

10.2

8.3

1.39

1.36

0.53

2252

11180

(3006217) Methemoglobin/Hemoglobin.total in Arterial blood

2266

11248

2.13

220.68

10.3

8.4

0.66

0.67

0.36

2249

11168

(36304419) Bacteria [Presence] in Urine

6849

47725

1.63

220.21

4.1

3.1

—

(3012544) pH of Venous blood

3127

17432

1.92

219.89

4.5

3.7

7.38

0.23

115

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

1091

3927

2.86

214.92

1.9

1.5

—

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

2181

10851

2.12

210.62

1.9

1.7

—

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

2119

10484

2.12

207.48

1.6

1.5

—

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

1987

9592

2.17

207.25

11.3

9.2

—

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

1048

3792

2.84

204.28

1.9

1.6

—

(3015377) Calcium [Moles/volume] in Serum or Plasma

8092

59821

1.56

196.71

4.9

3.3

2.35

mmol/l

7.65

7184

51752

(3010421) pH of Blood

1167

4598

2.62

192.50

5.1

3.9

7.42

0.73

1057

4197

(3026782) Osmolality of Urine

5351

36043

1.64

191.81

3.8

2.9

530.26

539.52

mosm/kgh2o

2.53

4737

30777

(3007853) Bacteria identified in Skin by Aerobe culture

3387

20202

1.80

189.50

2.1

1.8

—

(40767503) Oxygen content in Capillary blood by calculation

1010

3728

2.78

189.40

3.0

2.5

16.11

0.02

525

1949

(3027315) Oxygen [Partial pressure] in Blood

1063

4029

2.71

189.39

5.1

4.0

8.43

8.51

kpa

0.82

1041

3919

(3000850) Epithelial cells [#/volume] in Urine

5542

37787

1.62

188.55

3.5

2.6

5.51

5.27

e6/l

0.73

5056

33766

(3020630) Protein [Mass/volume] in Serum or Plasma

2729

15261

1.90

187.77

3.2

2.5

64.99

66.41

g/l

17.27

2492

13695

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

5972

41681

1.59

183.39

3.0

2.4

—

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

7287

53338

1.55

181.10

4.5

3.1

34.29

35.18

u/l

0.53

6895

50262

(40758558) Short blood count panel - Blood

6075

42690

1.58

180.65

10.2

6.7

—

(3013290) Carbon dioxide [Partial pressure] in Blood

1042

4015

2.67

179.55

5.1

3.9

5.00

kpa

0.05

1020

3906

(3012501) Base excess in Blood by calculation

1041

4014

2.66

179.12

5.1

3.9

2.69

2.58

mmol/l

0.56

753

2741

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

2806

16213

1.83

173.06

3.3

3.0

196.54

233.83

ng/l

4.04

2566

14806

(3021589) Normoblasts [#/volume] in Blood

9421

73459

1.50

170.61

15.0

9.7

0.00

e9/l

0.96

7699

59995

(3037467) Urinalysis macro (dipstick) panel - Urine

13961

118008

1.52

169.87

6.1

4.4

—

(1616796) Gas panel - Central venous blood

1006

3950

2.61

166.70

4.3

3.6

—

(3028271) Lactate [Moles/volume] in Capillary blood

790

2758

2.92

164.03

2.2

1.8

1.68

1.72

mmol/l

0.47

776

2691

(3024354) Oxygen [Partial pressure] in Venous blood

2446

13770

1.87

163.30

3.9

3.1

4.55

4.51

kpa

0.40

2355

13286

(3027945) Reticulocytes/100 erythrocytes in Blood

3397

21138

1.71

161.27

3.1

2.3

1.94

1.77

14.42

3001

18461

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

215

266

8.12

160.27

1.2

1.1

—

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

2762

16251

1.80

159.44

2.4

2.2

0.20

0.21

g/l

3.00

2552

15038

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

3170

19463

1.73

157.65

3.3

2.6

9.40

9.02

umol/l

0.33

2740

16869

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

7298

54651

1.50

157.10

2.6

2.1

220.92

216.03

u/l

0.15

6895

50935

(3017181) Myelocytes/100 leukocytes in Blood

2501

14349

1.83

156.74

4.7

3.9

1.03

0.96

0.80

1205

4904

(3001122) Ferritin [Mass/volume] in Serum or Plasma

8903

69463

1.48

155.83

3.4

2.8

172.75

143.20

ug/l

7.56

8231

63413

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

794

2890

2.80

152.50

2.0

1.6

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

789

2886

2.79

150.11

1.7

1.4

—

(3022806) Fractional oxyhemoglobin in Capillary blood

661

2196

3.06

149.76

2.1

1.8

89.38

89.40

0.02

651

2164

(3015235) Bicarbonate [Moles/volume] in Capillary blood

1062

4535

2.40

146.84

3.5

3.0

25.00

24.81

mmol/l

0.76

1040

4435

(3022313) Gas panel - Capillary blood

1578

7942

2.06

145.49

4.9

3.5

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

724

2588

2.85

143.78

1.9

1.6

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

724

2588

2.85

143.78

1.9

1.6

—

(3036481) Cortisol [Moles/volume] in Serum or Plasma

2498

14679

1.79

143.76

2.7

2.2

363.02

377.42

nmol/l

2.54

2334

13361

(3028626) Oxygen [Partial pressure] in Capillary blood

949

3891

2.50

143.36

3.3

2.9

8.07

7.96

kpa

0.98

927

3795

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

1626

8325

2.02

142.91

4.5

4.0

24.23

24.13

mmol/l

0.60

1587

8108

(3018405) Lactate [Moles/volume] in Arterial blood

1338

6369

2.17

142.76

4.5

4.0

1.38

1.39

mmol/l

0.08

1312

6254

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

815

3143

2.64

139.74

7.3

5.1

4727.10

1686.00

iu/ml

0.33

153

466

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

4198

28475

1.58

139.21

3.7

3.0

2.81

2.64

e6/l

0.44

2331

15533

(3002179) Metamyelocytes/100 leukocytes in Blood

2261

13039

1.81

138.25

4.6

3.8

0.78

0.67

1.08

1046

4210

(4035726) Immunohistochemistry procedure

2538

15194

1.75

136.51

1.5

1.4

—

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

2613

15778

1.74

136.32

2.9

2.4

48.30

47.15

u/l

0.04

2242

13432

(3021440) Promyelocytes/100 leukocytes in Blood

2334

13648

1.79

136.11

4.8

4.0

0.12

0.11

0.29

1049

4228

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

695

2514

2.81

134.92

1.6

1.4

—

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

4429

30707

1.55

132.47

3.4

2.8

1.32

1.25

e6/l

0.20

2540

17647

(3023520) Reticulocytes [#/volume] in Blood

2600

15844

1.72

130.87

3.1

2.4

73.92

68.67

e9/l

9.62

1909

12077

(3009445) Proteinase 3 Ab [Units/volume] in Serum

1454

7379

2.03

130.58

1.7

1.5

16.62

15.82

u/ml

0.06

179

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

631

2205

2.91

130.57

1.6

1.4

—

(3005719) IgG [Mass/volume] in Serum or Plasma

2081

11941

1.82

128.87

3.6

2.7

10.12

10.64

g/l

5.06

1945

10890

(3021901) Oxygen saturation in Capillary blood

821

3322

2.52

127.38

3.2

2.8

—

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

1298

6398

2.09

126.07

4.0

3.2

2145.56

1544.51

u/ml

0.28

1100

5471

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

1135

5332

2.18

124.82

1.4

1.3

—

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

1271

6239

2.09

124.78

2.9

2.6

—

(3026493) Urate [Moles/volume] in Serum or Plasma

6166

46336

1.46

122.99

3.5

2.7

4405.01

5044.79

umol/l

0.60

5366

39946

(3019174) dRVVT (LA screen)

115

13.54

122.84

1.2

—

(3013707) Erythrocyte sedimentation rate by Westergren method

14361

125365

1.43

122.80

5.5

4.1

16.03

13.14

mm/h

71.82

13392

115081

(3042891) Cardiolipin IgM Ab [Mass/volume] in Serum

138

10.01

121.26

1.1

—

(3044009) aPTT.lupus sensitive (LA screen)

113

13.30

119.47

1.2

—

(3025159) Blasts/100 leukocytes in Blood

2170

12881

1.75

119.24

4.8

4.0

0.23

0.42

0.92

882

3522

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

1268

6326

2.06

119.05

2.5

2.2

484.59

593.34

ug/l

0.52

1201

5934

(3020891) Body temperature

1395

7216

1.99

118.39

5.5

4.7

—

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

1089

5150

2.17

117.64

1.8

1.7

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

900

3936

2.33

117.49

1.6

1.5

—

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

1338

6846

2.01

117.09

5.2

3.7

25.08

24.85

mmol/l

1.97

1246

6224

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

1436

7534

1.96

116.95

6.5

4.8

1.65

1.63

0.36

1339

7070

(3004588) Protein electrophoresis panel - Serum or Plasma

2134

12738

1.74

114.74

3.0

2.3

—

(3007930) Methemoglobin/Hemoglobin.total in Blood

1411

7419

1.96

114.11

6.6

4.9

0.88

0.89

0.25

1321

6956

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

2832

18249

1.63

113.91

4.8

3.5

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

621

2329

2.70

112.35

1.7

1.4

—

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

4691

33906

1.48

112.35

4.4

3.0

2.48

2.46

mmol/l

15.93

4140

29405

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

613

2286

2.72

112.14

1.8

1.4

—

(3004809) Band form neutrophils/100 leukocytes in Blood

707

2850

2.52

110.44

3.3

3.4

1.54

1.56

0.04

625

2502

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

628

2409

2.64

108.63

3.2

2.4

11181.10

5652.01

u/ml

0.20

144

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

2363

14710

1.67

108.48

5.7

3.7

1.22

1.23

mmol/l

1.23

2167

12691

(3004119) Hemoglobin [Mass/volume] in Venous blood

1876

11008

1.76

106.72

4.2

3.2

126.13

127.99

g/l

2.96

1838

10737

(3043409) Potassium [Moles/volume] in Arterial blood

1104

5517

2.05

102.86

4.8

4.2

3.89

mmol/l

0.13

1095

5462

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

519

1869

2.81

101.49

1.9

1.5

—

(3035350) Ketones [Presence] in Urine by Test strip

9998

83592

1.36

100.60

5.0

3.8

0.00

estimate

0.55

2406

16360

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

598

2343

2.59

99.06

6.9

6.1

11.73

11.96

mg/l

0.58

545

2121

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

973

4705

2.11

98.95

1.8

1.6

1.21

1.18

g/l

2.79

917

4452

(3021601) Nitrite [Presence] in Urine by Test strip

9967

83505

1.36

97.89

6.6

5.1

0.00

estimate

1.84

2264

15236

(3028026) IgM [Mass/volume] in Serum or Plasma

1623

9356

1.79

97.76

2.3

1.9

1.20

1.38

g/l

2.30

1494

8443

(3047181) Lactate [Moles/volume] in Blood

1112

5675

2.00

97.62

7.8

5.6

1.29

1.33

mmol/l

0.75

987

5022

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

811

3670

2.25

97.46

3.9

3.1

2278.98

614.88

u/ml

1.74

733

3335

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

947

4567

2.11

96.96

1.8

1.6

0.25

0.23

g/l

3.99

889

4303

(3009261) Glucose [Presence] in Urine by Test strip

10058

84490

1.35

96.57

5.0

3.9

0.00

estimate

1.61

2207

14890

(46235355) HIV 1 and 2 tests - Meaningful Use set

3068

20886

1.54

96.03

1.7

—

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

1523

8672

1.81

95.54

2.0

1.6

1.68

1.55

g/l

5.15

1320

7354

(40763470) Parainfluenza virus 4 RNA [Presence] in Isolate by NAA with probe detection

485

1743

2.81

95.20

1.7

1.5

—

(40763324) Parainfluenza virus 1 RNA [Presence] in Isolate by NAA with probe detection

485

1743

2.81

95.20

1.7

1.5

—

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

967

4740

2.08

94.80

1.7

1.4

15.51

15.29

iu/ml

0.02

103

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

1116

5762

1.98

94.72

1.8

1.6

234.91

259.00

titre

0.13

256

(3037522) Nuclear Ab [Titer] in Serum

3096

21201

1.53

94.14

1.4

1.3

547.14

531.95

titre

0.17

669

4622

(3027273) Bicarbonate [Moles/volume] in Venous blood

1557

8963

1.79

94.10

4.5

3.4

25.42

25.20

mmol/l

1.67

1509

8701

(3017143) Hepatitis C virus Ab [Presence] in Serum

2389

15478

1.60

92.55

1.6

—

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

18024

167013

1.49

90.66

28.6

15.2

27.45

25.08

mg/l

18.56

16559

134077

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

1354

7574

1.83

89.88

2.5

1.9

—

(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood

1440

8246

1.79

88.42

4.9

4.0

48.71

47.67

0.85

1424

8149

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

2498

16591

1.57

86.62

2.5

2.4

6.68

7.19

ug/l

0.42

2113

14194

(3006184) Hemoglobin [Mass/volume] in Capillary blood

852

4145

2.09

85.11

2.5

2.2

127.94

127.91

g/l

0.01

659

2955

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

374

1239

3.04

85.08

1.8

1.5

—

(3039000) Anion gap in Blood

824

3981

2.10

83.83

8.7

6.5

11.15

11.25

mmol/l

0.37

741

3573

(3018572) Chloride [Moles/volume] in Blood

824

3982

2.10

83.77

8.7

6.5

105.33

105.01

mmol/l

1.19

741

3574

(3003434) Protein [Mass/volume] in Pleural fluid

606

2600

2.36

82.45

1.4

1.5

33.76

32.11

g/l

2.37

549

2322

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

1239

6949

1.82

81.33

2.1

1.8

—

(3015736) pH of Urine

8140

67395

1.33

80.99

4.5

3.6

5.81

5.83

0.18

399

3996

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

823

4031

2.07

80.70

1.4

1.3

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

822

4030

2.07

80.39

1.5

1.3

—

(3034860) Kappa light chains.free [Mass/volume] in Serum

1109

6039

1.87

79.98

4.4

3.1

61.35

71.55

mg/l

0.38

868

4868

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

1084

5862

1.89

79.89

4.3

3.1

11.04

3.18

ratio

0.57

433

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

1107

6029

1.87

79.80

4.4

3.1

50.71

45.24

mg/l

0.19

864

4865

(3016724) Homocysteine [Moles/volume] in Serum or Plasma

322

1017

3.19

79.48

1.4

13.23

13.15

umol/l

0.07

305

956

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

8429

70307

1.32

78.95

2.6

2.2

76.55

1398.94

nmol/l

0.50

7561

62105

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1257

7157

1.80

78.43

2.6

2.2

3.78

3.71

g/l

0.83

1133

6355

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1259

7173

1.79

78.38

2.6

2.2

—

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1260

7181

1.79

78.36

2.6

2.2

7.51

7.44

g/l

0.71

1134

6371

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

2627

18037

1.51

77.61

1.6

1.5

—

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

2102

13740

1.58

77.59

4.3

3.7

102.25

92.73

ng/l

3.78

1812

11657

(3021960) Folate [Moles/volume] in Serum or Plasma

5459

42903

1.36

75.93

1.7

1.6

19.22

20.44

nmol/l

7.35

4755

36393

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

1095

6050

1.85

75.34

2.9

2.4

1.09

0.99

g/l

0.29

928

5092

(3045788) Cell count panel - Pleural fluid

447

1738

2.59

75.20

1.5

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

382

1373

2.80

74.99

1.8

1.4

—

(3023199) Leukocytes [#/volume] in Pleural fluid

540

2298

2.37

74.83

1.4

1.5

2144.44

2661.93

e6/l

0.57

387

1664

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1179

6700

1.80

73.94

2.7

2.3

3.04

2.96

g/l

1.94

1056

5888

(3013512) EKG study

6475

52400

1.33

73.53

4.9

4.1

—

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1178

6712

1.79

73.21

2.7

2.2

9.98

10.27

g/l

1.35

1043

5863

(3023183) Ammonium ion [Moles/volume] in Plasma

737

3597

2.08

72.91

2.6

31.64

33.91

umol/l

1.83

666

3200

(3023419) Bacteria identified in Sputum by Culture

594

2683

2.24

71.59

2.8

2.4

—

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

704

3406

2.09

71.28

1.7

1.6

—

(3000494) Fungus identified in Specimen by Culture

2765

19531

1.47

70.47

1.7

1.4

—

(3036782) Glucose [Moles/volume] in Pleural fluid

435

1732

2.53

69.68

1.3

1.4

5.98

6.37

mmol/l

1.97

402

1598

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

429

1699

2.55

69.50

2.0

1.6

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

384

1442

2.68

69.29

1.9

1.6

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

384

1442

2.68

69.29

1.9

1.6

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

384

1442

2.68

69.29

1.9

1.6

—

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

964

5276

1.86

68.26

2.5

2.3

0.03

g/l

0.06

877

4769

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

405

1587

2.57

67.08

2.0

1.7

—

(3012441) Differential panel - Pleural fluid

473

1996

2.39

66.81

1.5

—

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

11964

105926

1.29

66.58

4.0

3.1

62.19

51.55

u/l

17.98

11171

97514

(3028308) Erythrocytes [#/volume] in Pleural fluid

486

2094

2.34

65.48

1.4

1.5

55635.57

58102.66

e6/l

0.07

286

1251

(40761536) Microorganisms panel - Urine sediment

2092

14159

1.52

65.41

5.6

4.1

—

(3019309) Folate [Moles/volume] in Red Blood Cells

4674

36667

1.35

63.75

1.9

1.8

1161.17

1163.64

nmol/l

0.06

3587

27323

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

1300

7914

1.68

63.53

5.7

3.4

101.13

62.56

u/ml

2.07

1254

7608

(3008757) Leukocyte morphology finding [Identifier] in Blood

449

1898

2.38

63.18

4.3

3.7

—

(3042631) Mycobacterium sp identified in Specimen

544

2515

2.18

61.90

2.6

—

(3019977) pH of Arterial blood

291

1004

2.91

61.68

2.7

2.5

7.43

7.42

1.23

109

369

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

893

4930

1.84

61.43

2.5

2.3

0.00

g/l

1.64

808

4445

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

977

5573

1.78

60.29

2.5

2.2

36.54

37.49

g/l

5.08

849

4746

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

502

2280

2.22

59.70

1.1

—

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

876

4854

1.83

59.53

2.6

2.3

0.00

g/l

-0.00

807

4427

(40760888) Immunoglobulin light chains.free panel - Serum

832

4542

1.86

59.30

4.8

3.2

—

(3017354) Segmented neutrophils/100 leukocytes in Blood

422

1787

2.38

59.16

3.6

3.4

60.58

57.12

2.68

361

1482

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

275

947

2.92

58.51

1.9

1.4

—

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

789

4291

1.86

56.90

1.6

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

272

946

2.89

56.85

1.9

1.4

—

(40768806) Pleura Pathology biopsy report

455

2028

2.26

56.64

1.5

—

(3029937) Albumin [Presence] in Urine by Test strip

5577

45487

1.30

56.40

5.5

4.2

0.00

estimate

0.29

2129

14558

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

8695

74986

1.26

55.89

2.2

2.0

92.61

95.10

pmol/l

5.35

4939

38692

(3037121) Protein [Mass/volume] in Urine

1019

6020

1.72

55.53

4.1

2.9

0.30

0.32

g/l

0.27

523

2465

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

10460

92256

1.25

54.99

3.0

2.6

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

296

1103

2.70

54.31

1.8

1.4

—

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

783

4321

1.83

53.88

3.6

2.8

1.80

1.63

mg/l

5.00

723

3890

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

529

2554

2.09

53.84

1.3

1.2

285.23

285.67

u/ml

0.01

359

1605

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

555

2731

2.05

53.67

1.3

1.2

—

(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma

489

2296

2.15

53.53

1.8

21.41

24.18

ug/l

0.67

481

2232

(3025941) Bacteria identified in Stool by Culture

1400

9065

1.58

53.01

1.3

—

(3007164) IgA [Mass/volume] in Serum or Plasma

3729

29024

1.34

52.11

1.8

1.5

2.52

2.55

g/l

0.35

2372

16978

(3048929) Epstein Barr virus Ab [Presence] in Serum

696

3760

1.87

51.24

1.3

1.2

—

(3023420) DNA double strand Ab [Units/volume] in Serum

365

1565

2.35

49.80

1.6

1.4

47.28

24.69

iu/ml

1.07

(3011412) CD3 cells [#/volume] in Blood

342

1425

2.41

49.77

2.3

1.46

1.14

e9/l

0.59

314

1294

(3041096) Erythrocytes [Presence] in Urine by Automated

5331

43828

1.28

49.34

4.8

3.5

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

242

856

2.84

49.09

2.2

1.8

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

242

857

2.83

48.99

2.2

1.8

—

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

571

2934

1.96

48.89

1.6

1.4

—

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

1095

6817

1.63

48.77

2.0

1.9

38.22

38.76

u/l

0.36

964

5907

(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction

396

1777

2.24

48.55

1.3

450.27

480.80

u/l

0.16

369

1685

(3021879) Hepatitis B virus core Ab [Presence] in Serum

1495

10046

1.52

47.72

1.4

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

281

1091

2.59

47.55

1.3

1.1

—

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

7470

64147

1.25

47.24

5.4

4.1

—

(3044889) 12 lead EKG panel

13139

119953

1.24

46.44

4.8

4.0

—

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

517

2619

1.99

46.13

1.6

1.4

110.66

118.36

u/ml

0.96

129

590

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

269

1040

2.60

45.93

2.0

—

(3017569) Oxygen content in Arterial blood

230

821

2.81

45.90

2.4

2.2

—

(3052851) Hemolysis interference index of Serum or Plasma

915

5525

1.68

45.89

3.9

3.3

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

202

674

3.00

45.57

2.4

2.0

—

(3005322) IgE [Units/volume] in Serum or Plasma

1354

9014

1.53

45.08

1.4

1.3

208.04

243.00

u/ml

0.74

1252

8267

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

199

664

3.00

44.90

2.4

2.0

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

199

664

3.00

44.90

2.4

2.0

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

394

1829

2.17

44.45

1.1

—

(3044242) Glucose [Moles/volume] in Arterial blood

233

852

2.74

44.44

2.2

2.0

—

(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood

272

1085

2.52

43.55

2.0

15.00

16.20

0.97

264

1050

(3011397) Hemoglobin [Presence] in Urine by Test strip

4896

40358

1.27

43.29

4.6

3.8

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

370

1695

2.19

43.16

3.1

2.8

—

(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid

325

1412

2.31

43.07

1.3

11.63

13.76

u/l

1.69

295

1302

(40768797) Stomach Pathology biopsy report

3057

23704

1.33

42.92

1.3

1.2

—

(1175426) CD3 cells/100 lymphocytes in Blood

274

1108

2.48

42.62

2.0

72.28

72.14

0.04

265

1051

(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma

313

1358

2.31

41.63

1.5

1.4

12.05

13.05

u/l

1.52

299

1307

(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay

211

759

2.79

41.55

1.8

2.0

101.45

95.51

1.36

187

714

(40768804) Tissue Pathology biopsy report

7865

68565

1.23

41.53

2.4

2.1

—

(3024980) IgG subclass 4 [Mass/volume] in Serum

481

2472

1.96

41.20

1.6

0.75

0.81

g/l

0.50

364

1857

(3024928) Oxygen saturation in Venous blood

656

3722

1.78

41.15

3.6

3.0

—

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

789

4721

1.69

40.93

1.6

0.30

8.86

iu/ml

1.71

183

1081

(4200892) Spirometry reversibility

1745

12446

1.43

40.89

1.5

1.4

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

270

1108

2.44

40.71

1.2

1.1

—

(3035637) Corticotropin [Mass/volume] in Plasma

396

1906

2.09

40.71

1.6

1.5

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

269

1107

2.44

40.32

1.2

1.1

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

269

1109

2.43

40.16

1.2

1.1

—

(3037756) Immunofixation for Serum or Plasma

695

4042

1.74

40.00

2.0

1.6

—

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

137

5.54

39.89

1.2

—

(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence

612

3434

1.80

39.86

1.4

1.2

225.00

125.35

titre

0.35

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

269

1114

2.42

39.77

1.2

1.1

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

269

1115

2.42

39.69

1.2

1.1

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

269

1116

2.42

39.62

1.2

1.1

—

(3022145) Colonoscopy Study observation

2482

18892

1.35

39.21

1.4

1.3

—

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

503

2677

1.89

38.83

1.7

1.4

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

174

586

2.97

38.70

1.6

1.4

—

(21494815) CD4 cells/100 lymphocytes in Specimen

289

1252

2.32

38.60

2.0

2.1

37.68

38.11

0.16

280

1226

(3010375) cycloSPORINE [Mass/volume] in Blood

184

645

2.86

38.07

34.1

26.6

115.88

111.93

ug/l

0.37

156

534

(3035880) pH of Pleural fluid

253

1045

2.43

37.65

1.3

—

(3019550) Sodium [Moles/volume] in Serum or Plasma

18226

174016

1.30

37.49

31.5

17.8

139.48

139.63

mmol/l

11.74

17961

169394

(3003694) ABO and Rh group [Type] in Blood

5121

43154

1.24

36.13

1.4

—

(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection

160

535

2.99

36.07

1.7

1.8

13351.24

44942.69

u/ml

0.64

(3019225) pH of Specimen

2375

18189

1.34

35.78

6.4

4.2

—

(3016628) Fibrinogen Ag [Mass/volume] in Platelet poor plasma by Immunoassay

117

327

3.58

35.30

1.5

1.2

170.91

21.00

mg/l

1.33

247

(3023103) Potassium [Moles/volume] in Serum or Plasma

18236

174449

1.29

34.59

31.7

17.9

4.00

3.98

mmol/l

13.06

17959

169512

(3026250) Tacrolimus [Mass/volume] in Blood

174

625

2.79

34.45

39.3

33.6

7.20

7.35

ug/l

0.41

161

557

(3000570) Elastase.pancreatic [Mass/mass] in Stool

816

5145

1.60

34.40

1.5

1.4

261.21

268.01

ug/g

0.41

483

3052

(4062490) Immunoglobulin typing, IgG

324

1548

2.10

34.04

1.4

—

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

632

3746

1.70

33.97

1.5

1.3

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

529

2982

1.79

33.96

1.8

1.5

—

(3020876) Protein [Mass/time] in 24 hour Urine

397

2044

1.95

33.90

3.1

2.4

1.12

1.22

g/24h

0.37

235

945

(3027135) IgG subclass 1 [Mass/volume] in Serum

323

1553

2.09

33.38

1.4

6.56

6.90

g/l

0.82

228

1077

(3010503) CD19 cells [#/volume] in Blood

226

939

2.41

33.26

2.4

2.5

0.34

0.40

e9/l

0.12

219

903

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

763

4776

1.61

33.15

2.0

1.7

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

360

1806

2.00

33.13

3.7

3.6

—

(3024139) IgG subclass 3 [Mass/volume] in Serum

322

1552

2.08

33.07

1.4

0.37

0.44

g/l

2.83

227

1080

(3024891) Influenza virus A+B Ag [Presence] in Specimen

673

4091

1.66

32.88

1.2

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

444

2399

1.86

32.75

1.1

—

(3028192) IgG subclass 2 [Mass/volume] in Serum

321

1554

2.07

32.59

1.4

2.77

2.95

g/l

0.92

228

1081

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

154

535

2.88

32.47

2.6

2.5

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

154

535

2.88

32.47

2.6

2.5

—

(3000012) Reticulocyte production index

489

2747

1.79

31.78

2.8

2.1

—

(3000492) Spirometry study

1985

15082

1.34

31.32

1.6

1.5

—

(3040151) Glucose [Moles/volume] in Capillary blood

399

2122

1.89

30.94

23.7

7.9

7.19

7.58

mmol/l

1.31

351

1729

(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay

332

1659

2.01

30.92

4.7

3.6

86.96

47.71

u/ml

1.92

327

1628

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

699

4361

1.62

30.79

2.0

1.9

11.77

11.47

mg/l

0.36

638

4017

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

283

1340

2.12

30.49

1.2

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

290

1391

2.09

30.21

2.5

2.4

—

(3021788) Differential panel - Synovial fluid

552

3257

1.71

30.20

1.6

1.5

—

(3017732) Neutrophils [#/volume] in Blood

1563

11511

1.38

30.09

3.9

2.9

5.24

5.09

e9/l

0.13

1201

8937

(3008536) Aspergillus sp Ab [Presence] in Serum

106

310

3.42

29.91

2.7

2.0

—

(3015171) Extractable nuclear Ab [Units/volume] in Serum

915

6110

1.51

29.87

1.3

1.2

0.72

1.04

u/ml

0.56

568

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

206

863

2.39

29.82

1.2

—

(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma

285

1375

2.08

29.25

2.5

1.8

4.08

4.11

mg/l

0.03

270

1300

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

527

3101

1.71

29.14

4.2

3.0

—

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

1847

14051

1.34

28.80

3.7

2.7

61.10

62.90

ml/min/173m2

0.92

858

5723

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

634

3929

1.63

28.72

1.3

6.93

5.38

u/ml

0.15

411

(3014702) Chromogranin A [Moles/volume] in Serum or Plasma

369

1975

1.88

28.10

3.4

3.3

10.75

9.84

nmol/l

0.09

354

1918

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

637

3991

1.61

27.60

1.3

7.72

6.28

u/ml

0.30

113

639

(40762365) Oxygen content in Arterial blood by calculation

100

297

3.36

27.58

3.0

2.7

14.99

14.88

ml/dl

0.13

274

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

214

946

2.27

27.42

2.5

0.23

0.24

e9/l

0.33

186

834

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

124

421

2.94

27.34

1.1

89.02

86.96

0.25

198

(3046294) Neutrophil cytoplasmic Ab.classic [Titer] in Serum

265

1277

2.08

27.32

1.2

110.00

134.26

titre

0.23

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

265

1278

2.08

27.26

1.2

189.29

163.63

titre

0.23

226

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

3298

27213

1.24

27.10

1.3

41.89

37.31

iu/ml

0.32

1015

8667

(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay

159

620

2.57

26.90

1.5

1.9

188.46

154.77

3.97

143

576

(21494814) CD8 cells/100 lymphocytes in Specimen

155

597

2.60

26.89

1.9

—

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

219

989

2.22

26.66

2.5

713.20

507.41

e6/l

0.64

183

841

(3034770) Mitochondria Ab [Titer] in Serum

672

4312

1.57

26.32

1.2

1320.91

845.44

titre

0.72

136

(3000475) Leukocytes [#/volume] in Synovial fluid

676

4347

1.57

26.23

1.8

1.6

15363.75

14765.17

e6/l

0.10

468

3145

(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma

401

2252

1.79

26.16

2.5

2.6

132.27

878.67

u/ml

1.07

395

2221

(3045142) Bone marrow Pathology biopsy report

354

1915

1.85

26.11

1.3

—

(40761535) Cells panel - Urine sediment

1942

15086

1.31

26.02

4.6

3.5

—

(3002385) Erythrocyte distribution width [Ratio]

15009

141800

1.18

25.99

32.0

17.9

15.53

15.19

8.02

14824

139107

(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

545

3337

1.64

25.94

1.2

6.04

12.78

u/ml

0.49

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

133

483

2.75

25.92

1.2

—

(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma

539

3295

1.65

25.82

1.5

1.4

308.34

160.16

pmol/l

2.86

526

3209

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

670

4318

1.56

25.75

1.3

1.2

42.73

40.83

u/ml

0.05

256

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

137

508

2.70

25.66

1.9

—

(3042733) HLA Ab [Presence] in Serum

128

460

2.78

25.46

4.6

5.0

—

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

540

3318

1.64

25.35

1.3

1.2

5.73

4.79

u/ml

0.11

246

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

214

3.69

25.09

2.2

1.8

—

(3036035) von Willebrand factor (vWf) Ag actual/normal in Platelet poor plasma by Immunoassay

128

464

2.76

25.05

1.4

2.0

221.50

179.31

2.96

121

437

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

4517

38762

1.20

24.96

1.8

1.7

22653713.09

30068034.86

pmol/l

0.40

3686

31509

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

200

896

2.23

24.87

2.5

2.8

37.62

38.94

0.38

112

514

(3024932) HLA-DR beta [Type]

126

456

2.76

24.75

1.2

1.1

—

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

228

1081

2.11

24.59

2.4

2.5

886.20

647.58

e6/l

0.53

215

1033

(3014765) Yersinia sp identified in Stool by Organism specific culture

729

4839

1.52

24.50

1.2

—

(42529406) Shigella sp [Presence] in Stool by Culture

730

4850

1.52

24.43

1.2

—

(3030981) Hyaline casts [#/volume] in Urine by Automated count

1301

9624

1.37

24.26

3.8

2.7

0.42

0.28

e6/l

1.40

1267

9408

(3029080) Hemoglobin [Entitic mass] in Reticulocytes

413

2392

1.73

24.25

2.8

2.0

32.31

32.65

0.76

404

2374

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

296

1552

1.91

24.09

1.3

1.2

—

(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay

5.70

23.92

1.1

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

198

899

2.20

23.85

3.5

3.7

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

638

4139

1.55

23.83

1.2

1.3

—

(3044941) Cell count panel - Synovial fluid

461

2769

1.67

23.68

1.5

1.4

—

(40768446) Kidney Pathology biopsy report

145

577

2.51

23.58

1.7

1.6

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

171

735

2.33

23.48

1.2

1.1

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

718

4795

1.51

23.45

1.2

—

(3024471) HLA-A [Type]

126

470

2.68

23.37

1.0

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

186

831

2.24

23.31

3.3

3.4

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

249

1245

2.00

23.29

1.5

1.4

—

(3008037) Lactate [Moles/volume] in Venous blood

640

4189

1.54

22.97

4.1

3.3

1.56

1.62

mmol/l

0.96

626

4097

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

415

2452

1.70

22.69

1.1

—

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

16471

157423

1.19

22.52

25.3

14.4

76.20

77.34

ml/min/173m2

8.80

14508

130282

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

714

4806

1.50

22.46

1.6

1.4

—

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

3067

25573

1.23

22.44

1.3

17.17

13.58

u/ml

0.64

1081

9450

(3004451) EKG impression Narrative

195

903

2.16

22.39

1.3

—

(3048689) Calprotectin [Mass/mass] in Stool

2261

18245

1.26

22.27

2.5

2.2

171.86

143.94

ug/g

2.48

1821

14203

(21494890) Protein electrophoresis panel - 24 hour Urine

346

1953

1.78

22.27

2.7

1.9

—

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

13454

126625

1.16

22.09

4.4

4.0

15.01

14.91

pmol/l

3.85

12247

113812

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

2128

17072

1.27

22.00

1.9

1.7

1.57

1.50

3.48

1805

14726

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

242

1225

1.98

21.89

1.5

1.4

—

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

463

2859

1.63

21.38

2.3

2.1

6096.45

4504.65

u/l

0.50

159

1081

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

254

3.22

21.25

1.3

—

(3001893) Eosinophils/100 leukocytes in Pleural fluid

143

595

2.40

21.18

1.3

1.4

2.38

2.77

0.22

123

494

(3025468) Yersinia sp identified in Specimen by Organism specific culture

375

2200

1.71

21.08

1.7

1.4

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

191

899

2.13

21.07

1.6

1.4

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

191

899

2.13

21.07

1.6

1.4

—

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

1292

9778

1.34

20.71

3.1

3.3

4.29

4.42

pmol/l

4.53

1132

8601

(3005988) Vibrio sp identified in Specimen by Organism specific culture

374

2206

1.70

20.63

1.7

1.4

—

(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma

434

2662

1.64

20.60

4.6

3.5

48.22

36.83

u/ml

0.97

421

2574

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

373

2204

1.70

20.44

1.7

1.4

—

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

125

497

2.51

20.44

1.1

—

(3038515) Glucose [Moles/volume] in Venous blood

602

3990

1.52

20.42

4.3

3.4

7.42

7.70

mmol/l

1.79

588

3911

(3005532) Lymphocytes/100 leukocytes in Pleural fluid

159

706

2.25

20.30

1.4

63.76

63.97

0.02

129

577

(3024522) Salmonella sp identified in Specimen by Organism specific culture

377

2239

1.69

20.28

1.7

1.4

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

276

1499

1.84

20.22

1.4

1.5

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

382

2281

1.68

20.14

1.7

1.4

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

374

2222

1.69

20.09

1.7

1.4

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

616

4125

1.50

19.90

1.3

—

(3021162) Amylase [Enzymatic activity/volume] in Specimen

270

3.07

19.85

2.6

2.8

1273.43

1953.98

u/l

0.31

245

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

235

1220

1.93

19.80

1.3

1.2

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

182

862

2.11

19.79

2.4

—

(3008832) Norclozapine [Moles/volume] in Serum or Plasma

154

683

2.25

19.73

12.0

12.2

913.78

839.88

nmol/l

0.91

148

650

(3023383) Lactate [Moles/volume] in Pleural fluid

139

590

2.35

19.73

1.3

3.76

3.33

mmol/l

0.87

124

543

(43055246) Days in therapeutic INR range/Days INR result determined [Ratio]

113

437

2.58

19.59

8.0

5.1

70.48

69.61

0.15

341

(3006109) Coagulation factor IX activity actual/normal in Platelet poor plasma by Coagulation assay

294

2.95

19.48

1.3

1.2

114.49

108.66

0.52

281

(3013727) Leukocytes other/100 leukocytes in Blood

134

563

2.38

19.47

3.5

3.6

57.58

53.12

1.66

128

543

(3002256) Pathology report gross observation

2698

22504

1.22

19.45

1.3

—

(3007566) Smooth muscle Ab [Titer] in Serum

641

4352

1.48

19.36

1.2

101.70

141.36

titre

0.99

383

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

119

476

2.50

19.24

1.1

—

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

452

2850

1.59

19.19

1.3

53.53

35.67

u/l

1.10

400

2442

(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay

111

430

2.58

19.19

1.2

1.1

101.91

105.49

0.41

101

392

(3000081) cloZAPine [Moles/volume] in Serum or Plasma

157

715

2.20

18.89

16.2

17.3

1508.31

2759.05

nmol/l

0.46

150

690

(3034459) Mononuclear cells/100 leukocytes in Pleural fluid

213

3.28

18.72

1.3

1.4

65.07

75.98

1.93

175

(40757494) Bilirubin.total [Moles/volume] in Blood

193

958

2.02

18.54

2.5

2.1

17.60

27.76

umol/l

0.81

(3006576) Bicarbonate [Moles/volume] in Blood

144

638

2.26

18.53

5.3

6.4

25.04

25.05

mmol/l

0.00

136

573

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

289

1636

1.77

18.51

1.2

1.3

—

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

204

1037

1.97

18.32

1.5

1.3

2.22

1.33

u/ml

0.69

121

595

(3044290) Cell count panel - Cerebral spinal fluid

478

3087

1.55

18.31

1.5

1.3

—

(3006245) CD3-CD19+ cells/100 cells in Blood

122

506

2.41

18.27

2.0

10.36

10.20

0.04

109

461

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

207

1059

1.96

18.25

2.0

1.7

—

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

299

1717

1.74

18.23

1.1

—

(3009466) Valproate [Moles/volume] in Serum or Plasma

373

2274

1.64

18.20

5.3

4.7

351.04

356.99

umol/l

0.33

316

1915

(3022493) Free Hemoglobin [Mass/volume] in Plasma

156

721

2.16

18.11

3.8

4.2

981.40

1004.25

mg/l

0.01

121

497

(40768441) Liver Pathology biopsy report

222

1168

1.90

18.02

1.2

1.3

—

(21491868) Cryoglobulin [Mass/volume] in Serum

129

554

2.33

17.88

1.3

1.2

0.63

0.22

g/l

—

(3018461) Alpha 1 globulin [Mass/time] in 24 hour Urine by Electrophoresis

210

3.23

17.78

5.8

4.9

63.59

47.52

ug/min

0.95

165

(3012565) Volume of 24 hour Urine

174

845

2.06

17.77

2.4

2.1

1833.84

1932.76

0.65

160

727

(3001964) Herpes simplex virus Ag [Presence] in Specimen

113

462

2.44

17.49

1.7

1.4

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

278

1587

1.75

17.33

1.2

1.1

—

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

104

415

2.50

16.96

1.1

86.83

86.43

0.03

198

(3049717) Cytology report of Urine Cyto stain

992

7438

1.34

16.93

2.6

2.8

—

(3007449) CD3+CD8+ (T8 suppressor) cells/100 cells in Blood

119

507

2.34

16.83

2.0

30.52

29.43

0.28

111

473

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

574

3933

1.47

16.60

1.4

—

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

361

2237

1.62

16.54

1.7

1.5

58.28

59.90

0.32

221

1403

(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay

284

2.81

16.46

1.1

1.2

95.57

77.22

2.93

(3009214) Lutropin [Units/volume] in Serum or Plasma

501

3347

1.50

16.45

1.5

1.3

12.38

10.84

u/l

1.37

420

2718

(3009508) Creatinine [Moles/volume] in Urine

6139

55465

1.14

16.41

3.5

3.2

7.40

7.35

mmol/l

0.34

5080

46128

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

329

2.67

16.40

1.2

—

(3051651) Icteric interference index of Serum or Plasma

203

1075

1.89

16.21

5.2

3.8

—

(3014271) Vancomycin [Susceptibility]

209

1118

1.87

16.18

3.3

3.0

—

(3019150) Specific gravity of Urine by Refractometry

4221

37169

1.16

16.11

5.5

4.3

1.02

kg/l

0.46

652

5761

(3033705) Calcium.ionized [Moles/volume] in Venous blood

385

2441

1.58

16.05

2.9

2.4

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

542

3703

1.47

15.93

1.2

—

(3024666) Lithium [Moles/volume] in Serum or Plasma

149

713

2.09

15.88

13.7

12.1

0.64

0.63

mmol/l

0.40

138

649

(4281824) Cell count and differential, peritoneal fluid

300

1794

1.67

15.84

1.2

1.1

—

(3000919) Neutrophils/100 leukocytes in Pleural fluid

121

534

2.26

15.80

1.3

1.4

21.38

20.58

0.12

114

475

(40766799) MGMT gene methylation score in Tissue by Molecular genetics method

106

4.05

15.70

1.0

—

(3052318) Alpha-1-Microglobulin [Mass/volume] in Urine

232

2.97

15.68

2.9

2.5

114.34

71.36

mg/l

—

(40757373) Influenza virus identified in Isolate

366

2.54

15.66

1.7

1.5

—

(3026051) Polymorphonuclear cells/100 leukocytes in Pleural fluid

109

462

2.36

15.63

1.4

27.31

20.92

1.32

388

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

430

2813

1.53

15.61

1.2

—

(3045414) Leukocytes [Presence] in Urine

1006

7660

1.32

15.46

2.1

1.9

—

(21494755) Public health laboratory ask at order entry panel

876

11513

0.75

15.45

1.4

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

202

1088

1.86

15.33

1.9

1.8

—

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

530

7522

0.69

15.09

1.4

1.5

—

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

463

3108

1.49

14.89

1.3

1.2

39.70

48.73

u/ml

0.62

318

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

885

11553

0.75

14.88

1.7

1.8

—

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

492

3345

1.48

14.86

1.6

1.4

1434.22

2169.35

e6/l

0.38

410

2743

(3039162) Centromere protein B Ab [Units/volume] in Serum

316

1948

1.62

14.85

1.3

47.72

57.98

u/ml

0.26

141

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

144

699

2.06

14.81

1.7

1.8

111.55

115.14

umol/l

0.04

361

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

181

952

1.90

14.81

1.1

—

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

336

2105

1.60

14.77

1.1

1.52

1.53

g/l

0.18

311

1897

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

181

956

1.89

14.62

1.1

—

(3015401) Amylase [Enzymatic activity/volume] in Pleural fluid

232

2.88

14.48

1.3

1.2

650.92

192.79

u/l

0.40

163

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

489

3344

1.47

14.35

1.5

1.4

26.85

31.04

e6/l

0.14

388

2603

(3012516) Albumin [Mass/volume] in Urine

5902

53563

1.13

14.29

3.6

3.2

675.08

396.77

mg/l

3.19

3875

33974

(3003181) Sodium [Moles/volume] in Urine

491

3365

1.46

14.25

1.3

1.4

63.54

62.19

mmol/l

0.30

369

2689

(43055458) Rivaroxaban [Mass/volume] in Serum or Plasma

182

3.12

14.19

1.2

1.3

97.21

108.86

ug/l

0.22

119

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

548

3838

1.43

14.18

1.4

1.3

573.53

552.99

mg/l

0.32

528

3633

(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay

285

2.66

14.15

1.1

1.2

83.30

70.10

1.57

(3042010) Triglyceride [Moles/volume] in Pleural fluid

253

2.76

13.99

1.3

1.2

1.30

1.47

mmol/l

0.10

157

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

167

874

1.91

13.90

1.4

1.5

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

167

874

1.91

13.90

1.4

1.5

—

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

300

2.59

13.82

1.2

—

(40761511) CBC panel - Blood by Automated count

17724

171927

1.16

13.81

25.3

14.4

—

(3000330) Specific gravity of Urine by Test strip

1176

9283

1.28

13.78

4.7

3.7

—

(3003129) Base excess in Capillary blood by calculation

105

465

2.25

13.67

1.9

1.7

0.87

0.54

mmol/l

0.31

437

(3000093) Morphology [Interpretation] in Blood Narrative

286

1761

1.63

13.55

1.2

1.1

—

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

3768

33291

1.15

13.45

1.3

1.2

1.38

1.72

u/ml

1.61

975

8638

(3020682) Albumin/Creatinine [Ratio] in Urine

6192

56537

1.13

13.40

4.2

3.8

11.79

9.07

mg/mmol

4.07

3945

35452

(3047189) Immunofixation for 24 hour Urine

161

844

1.91

13.36

2.0

1.7

—

(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma

243

2.75

13.33

1.4

1.2

152.46

456.41

ng/l

0.44

163

(3006922) Hepatitis E virus Ab [Presence] in Serum

187

1033

1.81

13.16

1.1

—

(3028707) Methadone [Presence] in Urine by Screen method

255

1538

1.66

13.12

3.2

2.8

—

(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum

222

1291

1.72

13.10

1.2

76.23

79.60

u/ml

0.05

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

134

664

2.02

13.09

2.7

2.6

—

(3029075) Extractable nuclear Ab panel - Serum

424

2.28

13.04

1.1

—

(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum

222

1296

1.71

12.92

1.2

27.61

43.40

u/ml

0.70

107

(3023487) Leukocytes [#/volume] in Peritoneal fluid

125

608

2.05

12.86

1.8

2.0

2445.78

2970.50

e6/l

0.10

425

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

483

3375

1.43

12.70

1.3

1.2

3.82

3.81

mmol/l

0.07

448

3165

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

271

1675

1.62

12.68

1.7

1.5

29.94

28.65

0.22

162

1019

(21494434) Karyotype in Bone marrow

248

1503

1.65

12.55

1.2

—

(3051611) Lipemic interference index of Serum or Plasma

305

1948

1.57

12.44

4.5

3.3

—

(3014891) Appearance of Pleural fluid

281

2.56

12.43

1.3

—

(3023511) Choriogonadotropin [Units/volume] in Urine

226

1342

1.68

12.38

1.4

1.3

—

(3036180) Methadone [Presence] in Urine

100

453

2.20

12.37

2.3

2.5

—

(3010838) Calcium [Moles/time] in 24 hour Urine

433

2981

1.46

12.34

1.8

4.76

4.97

mmol/24h

0.61

375

2584

(3035947) Staphylolysin Ab [Units/volume] in Serum

158

847

1.86

12.28

1.1

6.07

4.24

iu/ml

0.38

(3000060) B lymphocytes [#/volume] in Blood

337

2.40

12.22

1.9

2.0

117.07

680.87

e6/l

1.52

184

(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay

211

1238

1.70

12.09

1.2

2.24

4.38

u/ml

—

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

4.57

12.01

1.3

—

(1761868) Lipid panel - Serum or Plasma

4945

53959

0.89

12.01

3.2

3.0

—

(3004616) Nuclear Ab [Presence] in Serum

308

1998

1.54

11.75

1.3

—

(3038026) Centromere Ab [Units/volume] in Serum

222

1335

1.66

11.62

1.2

40.00

49.19

u/ml

—

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

3.66

11.54

1.1

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

913

7147

1.28

11.47

1.3

1.4

—

(3021387) Prolactin [Units/volume] in Serum or Plasma

505

3628

1.40

11.39

1.8

1.7

321.63

293.31

mu/l

1.13

462

3293

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

15853

153156

1.12

11.27

5.4

4.8

2.07

2.11

mu/l

0.11

14532

138674

(3030136) 5-Hydroxyindoleacetate [Moles/volume] in Serum or Plasma

198

1167

1.70

11.20

3.5

3.4

162.73

141.52

nmol/l

0.26

193

1151

(3044927) Protein electrophoresis panel - Urine

296

1925

1.54

11.19

1.2

—

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

377

2.25

11.12

2.2

2.4

—

(3011288) Drugs identified in Urine by Screen method

336

2253

1.49

11.00

4.2

3.0

—

(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection

3.84

10.99

4.9

5.0

—

(40768443) Skin Pathology biopsy report

982

7800

1.27

10.97

1.2

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

208

1252

1.66

10.88

1.1

—

(3020191) Ethanol [Moles/volume] in Serum or Plasma

205

1233

1.66

10.76

1.6

1.4

1.15

1.31

promille

0.79

161

943

(3017704) Immunofixation for Urine

176

1017

1.73

10.72

1.9

1.5

—

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

108

534

2.02

10.71

1.7

1.9

22203.04

10606.14

e6/l

0.59

293

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

171

982

1.74

10.65

1.9

2.70

u/field

0.00

122

680

(3044007) Cell count panel - Peritoneal fluid

478

2.07

10.49

1.7

1.9

—

(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood

262

1687

1.55

10.40

1.2

1.1

2.14

2.12

iu/ml

—

(3020393) Adenovirus Ag [Presence] in Stool

162

2.89

10.36

1.1

—

(3034891) Synovial lining cells/100 cells in Synovial fluid

150

837

1.79

10.33

1.5

2.69

3.90

0.72

182

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

278

1821

1.53

10.22

1.8

1.7

—

(3045066) Thymidine kinase [Enzymatic activity/volume] in Serum

467

2.05

9.99

2.3

1.9

47.58

38.34

u/l

0.21

430

(40768795) Lymph node Pathology biopsy report

259

1683

1.54

9.89

1.2

—

(3016018) Differential panel - Cerebral spinal fluid

248

1600

1.55

9.79

1.6

1.4

—

(3003327) Ova and parasites identified in Stool by Light microscopy

655

5016

1.31

9.78

1.7

—

(3009871) Measles virus Ab [Titer] in Serum

471

2.03

9.77

1.6

1.7

—

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

18130

176937

1.14

9.74

17.0

10.6

26.62

25.82

u/l

3.47

17686

169787

(3008295) Osmolality of Serum or Plasma

265

1738

1.52

9.71

1.4

282.59

277.25

mosm/kgh2o

2.92

205

1314

(3028433) Virus identified in Specimen by Culture

107

547

1.95

9.71

1.2

—

(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma

420

2.09

9.65

1.5

0.35

0.39

ug/l

0.32

258

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

1154

9469

1.23

9.65

1.2

110.22

141.69

iu/ml

2.18

373

3477

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

371

2604

1.43

9.64

1.2

—

(3022621) pH of Urine by Test strip

1389

11610

1.20

9.62

3.6

3.1

—

(40761539) Cells [Type] in Urine sediment by Light microscopy

448

2.05

9.57

1.3

1.2

—

(3041918) Cholesterol [Moles/volume] in Pleural fluid

344

2.20

9.53

1.3

1.2

2.02

1.55

mmol/l

2.49

210

(3013005) Retinol [Moles/volume] in Serum or Plasma

107

557

1.92

9.23

1.7

1.6

2.07

1.98

umol/l

0.45

100

520

(3028029) Mesothelial cells/100 leukocytes in Pleural fluid

298

2.28

9.23

1.4

1.5

12.39

11.46

0.11

146

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

337

2349

1.44

9.13

2.4

2.1

29.60

25.88

mg/l

0.47

609

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

287

2.29

9.13

3.4

2.9

—

(3032352) Blasts [#/volume] in Cerebral spinal fluid

152

2.82

9.10

3.0

1.7

—

(3011985) Renin [Units/volume] in Plasma

321

2220

1.45

9.07

1.6

1.4

63.45

58.14

mu/l

0.19

290

1953

(3035509) Tobramycin [Mass/volume] in Serum or Plasma

175

2.68

9.02

3.0

3.2

1.71

1.07

mg/l

0.65

131

(3026389) Candida sp identified in Specimen by Organism specific culture

349

2455

1.42

8.99

1.4

—

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

466

1.99

8.97

3.2

3.0

—

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

396

2854

1.39

8.88

1.3

—

(3051593) INR in Capillary blood by Coagulation assay

161

960

1.67

8.84

10.9

10.7

—

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

235

1535

1.53

8.82

2.2

2.1

2.07

2.10

u/field

0.04

104

595

(3016750) Collection duration of Urine

172

1046

1.64

8.75

2.5

2.1

499.48

499.43

min

0.00

122

775

(3047007) Chlamydophila sp Ab [Presence] in Serum

287

1957

1.47

8.75

1.3

1.2

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

147

858

1.71

8.74

1.1

—

(43055442) Apixaban [Mass/volume] in Serum or Plasma

293

2.25

8.71

1.5

101.76

116.75

ug/l

0.65

242

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

124

690

1.79

8.70

1.4

1.2

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

144

838

1.72

8.66

1.1

—

(3019779) Phenytoin [Moles/volume] in Serum or Plasma

214

2.47

8.65

4.0

3.0

40.79

39.38

umol/l

0.16

176

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

219

1417

1.54

8.60

1.5

1.6

26.16

25.19

u/ml

0.09

297

(3017315) Amylase [Enzymatic activity/volume] in Urine

154

915

1.68

8.58

1.2

208.42

377.89

u/l

2.38

144

840

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

360

2.11

8.55

1.2

1.1

—

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

222

2.43

8.49

4.1

4.9

—

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

301

2084

1.44

8.49

1.1

15.59

11.09

au/ml

0.37

(3052592) Norovirus Ag [Presence] in Stool

381

2.07

8.49

1.3

—

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

143

839

1.70

8.36

1.5

—

(3007302) Hemoglobin [Mass/volume] in Mixed venous blood

4.27

8.33

12.1

11.8

—

(3002331) Protein [Mass/volume] in Peritoneal fluid

385

2.05

8.26

1.2

1.4

29.61

44.23

g/l

0.45

296

(3042951) Complement C1q Ab [Units/volume] in Serum

3.72

8.26

1.0

1.1

40.48

15.50

u/ml

—

(3046861) Legionella sp Ag [Presence] in Urine

3.22

8.25

1.1

—

(3004905) Lipase [Enzymatic activity/volume] in Serum or Plasma

295

2.20

8.17

5.8

4.5

42.80

72.79

u/l

1.43

286

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

291

2019

1.44

8.14

1.1

—

(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence

185

1168

1.58

8.12

1.3

70.00

58.06

titre

0.19

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

106

575

1.84

8.12

1.2

1.3

486.30

207.78

ug/l

0.59

316

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

498

3774

1.32

8.10

1.6

1.8

41.28

6.91

iu/l

0.71

169

1283

(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

168

2.61

8.08

1.1

1.0

—

(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma

111

612

1.81

8.07

1.7

1.5

30.26

29.25

umol/l

0.45

111

582

(3033670) Parathyrin related protein [Moles/volume] in Serum or Plasma

303

2.17

8.07

1.1

2.51

11.26

pmol/l

—

(3019832) Treponema pallidum Ab [Presence] in Serum

1024

8459

1.22

8.05

1.6

—

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

157

2.67

8.04

1.1

1.2

—

(1761482) Bacteria [#/volume] in Urine by Culture

645

5074

1.27

7.91

5.7

4.3

—

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

295

2066

1.43

7.86

1.4

1.3

285.67

352.21

pmol/l

0.66

258

1759

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

206

1346

1.53

7.79

1.0

1.1

—

(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence

188

1204

1.56

7.78

1.3

497.65

424.48

titre

0.09

105

(3033799) Differential panel - Peritoneal fluid

100

541

1.84

7.74

1.9

1.8

—

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

16473

167474

0.91

7.65

5.2

5.1

2.67

2.69

mmol/l

1.79

14971

152926

(3032057) Clostridioides difficile [Presence] in Stool

424

1.95

7.65

2.4

1.7

—

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

277

1935

1.43

7.51

1.2

63.79

60.59

u/l

0.33

261

1714

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

211

2.36

7.47

2.1

—

(3042517) Benzodiazepines panel - Urine

3.08

7.47

2.9

2.2

—

(3018851) Theophylline [Moles/volume] in Serum or Plasma

175

2.51

7.47

2.0

1.6

52.34

44.94

umol/l

0.65

175

(40763590) HLA-DQ beta [Type]

4.21

7.41

1.1

1.0

—

(46236302) HLA-C [Type] by High resolution typing

4.21

7.41

1.1

1.0

—

(3035999) Lactate [Moles/volume] in Cerebral spinal fluid

186

1204

1.54

7.36

1.4

1.3

2.27

2.16

mmol/l

0.51

174

1114

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

225

2.30

7.35

2.1

2.0

—

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

303

2159

1.40

7.35

1.3

—

(3033306) Mononuclear cells/100 leukocytes in Cerebral spinal fluid

122

712

1.71

7.34

1.6

1.2

46.73

62.91

0.81

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

417

1.94

7.32

1.1

—

(3026179) Normetanephrine [Moles/volume] in Serum or Plasma

326

2360

1.38

7.21

1.3

1.91

1.74

nmol/l

0.04

317

2257

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

326

2362

1.38

7.18

1.3

0.18

0.27

nmol/l

1.15

181

(3023323) Follitropin [Units/volume] in Serum or Plasma

614

4864

1.26

7.15

1.4

1.3

31.33

32.33

iu/l

0.30

512

4199

(3017446) Testosterone [Moles/volume] in Serum or Plasma

1382

11859

1.17

7.12

2.3

2.1

10.73

12.36

nmol/l

11.37

1204

10475

(3039602) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Capillary blood

293

2.11

7.10

1.9

1.7

1.20

1.19

mmol/l

0.19

283

(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma

517

1.81

6.95

1.4

1.3

3.63

3.80

umol/l

0.19

472

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

107

2.89

6.92

2.2

2.3

—

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

15953

162238

0.92

6.89

4.7

4.5

1.40

1.46

mmol/l

61.98

14483

147891

(3024263) Appearance of Synovial fluid

149

932

1.60

6.88

1.4

1.3

—

(40765096) Chromosome analysis panel by Banding

476

1.84

6.87

1.2

1.1

—

(44786800) Granulocytes/100 leukocytes in Body fluid

258

2.16

6.85

1.2

1.3

23.36

24.47

0.08

201

(3038071) Oxygen [Partial pressure] in Mixed venous blood

373

1.95

6.78

7.9

7.7

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

134

820

1.63

6.77

1.1

—

(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid

103

2.90

6.77

1.0

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

155

983

1.57

6.76

1.1

—

(3045424) Erythrocytes [Presence] in Urine

384

2885

1.33

6.72

1.6

1.5

—

(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination

231

1596

1.45

6.70

1.7

1.8

1616.00

2047.12

titre

—

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

118

701

1.68

6.69

3.3

2.4

—

(3009224) EGFR gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

3.61

6.68

1.0

—

(44816559) Phosphatidylethanol [Mass/volume] in Blood

357

2656

1.34

6.68

1.4

1.3

—

(3034274) Bile acid [Moles/volume] in Serum --fasting

176

1152

1.53

6.67

1.7

1.8

8.07

9.39

umol/l

0.31

138

830

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

404

1.90

6.62

1.1

—

(36660697) Celiac disease serology panel - Serum

1390

12003

1.16

6.62

1.2

—

(40760409) HLA-A [Type] by High resolution

3.99

6.56

1.1

1.0

—

(40760410) HLA-B [Type] by High resolution

3.99

6.56

1.1

1.0

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

399

1.90

6.53

1.1

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

407

1.89

6.49

1.1

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

126

772

1.63

6.37

1.1

—

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

171

2.39

6.35

1.2

1.1

—

(3043722) Hyaline casts [#/area] in Urine sediment by Automated count

4.03

6.30

1.2

1.0

1.29

1.19

u/field

0.18

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

405

1.87

6.26

1.1

—

(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection

565

1.73

6.23

1.4

1.5

5422080.00

1441256.16

iu/ml

—

(3023410) Appearance of Cerebral spinal fluid

214

1480

1.44

6.21

1.7

1.5

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

235

1656

1.42

6.16

1.1

—

(3024869) Neuronal Ab [Presence] in Serum

324

1.97

6.14

1.0

1.1

—

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

16123

163678

0.92

6.11

4.7

4.6

4.56

4.59

mmol/l

4.34

14757

150130

(3014051) Protein [Presence] in Urine by Test strip

573

4594

1.25

6.08

2.9

2.6

—

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

171

1137

1.50

6.07

1.6

4.02

7.03

u/l

3.22

135

911

(3013862) HLA-DP [Type]

3.74

6.03

1.1

1.0

—

(3001686) Cold agglutinin [Titer] in Serum or Plasma

313

1.98

6.01

1.3

1.4

90.13

213.03

titre

—

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

253

2.09

5.98

13.3

10.7

5.96

5.43

mmol/l

0.44

253

(3005665) Streptococcus pneumoniae Danish serotype 6B IgG Ab [Mass/volume] in Serum

3.07

5.97

1.5

1.6

2.61

1.77

mg/l

0.21

(3000899) Streptococcus pneumoniae Danish serotype 7F IgG Ab [Mass/volume] in Serum

3.07

5.97

1.5

1.6

0.99

2.12

mg/l

1.07

(36204005) Streptococcus pneumoniae Danish serotype 19F IgG Ab [Mass/volume] in Serum

3.07

5.97

1.5

1.6

2.98

3.08

mg/l

0.03

(36204187) Streptococcus pneumoniae Danish serotype 4 IgG Ab [Mass/volume] in Serum

3.07

5.97

1.5

1.6

0.34

1.22

mg/l

1.04

(3005260) Streptococcus pneumoniae Danish serotype 9V IgG Ab [Mass/volume] in Serum

3.07

5.97

1.5

1.6

0.81

1.38

mg/l

0.40

(36204286) Streptococcus pneumoniae Danish serotype 5 IgG Ab [Mass/volume] in Serum

3.07

5.97

1.5

1.6

1.69

1.88

mg/l

0.08

(36203922) Streptococcus pneumoniae Danish serotype 14 IgG Ab [Mass/volume] in Serum

3.07

5.97

1.5

1.6

3.65

4.11

mg/l

0.12

(36204094) Streptococcus pneumoniae Danish serotype 23F IgG Ab [Mass/volume] in Serum

3.07

5.97

1.5

1.6

1.24

3.68

mg/l

1.63

(3043410) Blood group antigens tested for on Red Blood Cells

491

1.77

5.97

1.8

1.7

—

(40771922) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood

128

2.57

5.96

1.5

1.3

0.66

1.02

ml/s/173m2

1.50

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

377

1.88

5.94

1.1

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

484

3817

1.27

5.93

4.8

3.6

29.66

28.33

mg/l

0.34

334

2464

(3035320) C reactive protein [Mass/volume] in Body fluid

182

1232

1.47

5.92

3.1

2.5

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

215

2.18

5.90

1.3

1.2

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

215

2.18

5.90

1.3

1.2

—

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

281

2.02

5.90

1.7

1.6

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

350

2653

1.32

5.82

2.7

2.2

—

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

437

1.80

5.81

8.1

7.7

—

(3047185) IgG [Mass/volume] in Urine

5.31

5.80

1.1

—

38.67

—

(3040491) Angiotensin converting enzyme [Enzymatic activity/volume] in Pleural fluid

198

2.22

5.76

1.1

22.46

18.18

u/l

0.55

136

(3004775) Volume in Urine collected for unspecified duration

212

1487

1.42

5.74

2.4

2.3

769.12

665.68

1.73

139

1005

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

354

1.89

5.70

1.1

—

(3050099) BK virus DNA [#/volume] (viral load) in Specimen by NAA with probe detection

4.84

5.70

3.1

3.8

—

(3000764) Benzodiazepines [Presence] in Urine

439

3440

1.28

5.69

2.6

2.1

—

(3016436) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma

133

851

1.56

5.66

2.8

2.4

226.73

207.27

u/l

1.22

133

843

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

1157

9978

1.16

5.64

2.6

2.4

—

(36203821) Streptococcus pneumoniae Danish serotype 1 IgG Ab [Mass/volume] in Serum

2.95

5.62

1.5

1.6

1.13

2.05

mg/l

0.58

(3028300) Cannabinoids [Presence] in Urine

442

3475

1.27

5.58

2.7

2.1

—

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

145

950

1.52

5.56

1.8

1.4

5.88

6.05

u/l

0.10

127

788

(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay

3.27

5.52

1.1

1.2

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

215

2.13

5.50

1.3

1.2

—

(3016879) Cocaine [Presence] in Urine

411

3213

1.28

5.45

2.7

2.1

—

(3026692) Albumin [Mass/volume] in Peritoneal fluid

447

1.76

5.42

1.3

1.4

15.41

13.55

g/l

0.90

338

(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine

153

2.34

5.40

4.9

2.5

—

(3027008) Opiates [Presence] in Urine

439

3464

1.27

5.40

2.6

1.9

—

(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma

109

674

1.61

5.38

2.0

2.3

49.85

53.29

umol/l

0.48

557

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

165

1120

1.47

5.35

1.3

1.2

92.19

92.37

u/l

0.01

154

963

(42870325) Hepcidin 25 amino acid peptide [Moles/volume] in Serum or Plasma

231

2.07

5.34

1.2

1.3

8.27

274101.37

nmol/l

1.52

193

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

205

2.14

5.32

1.4

1.6

—

(3016038) Potassium [Moles/volume] in Urine

176

1216

1.44

5.21

1.2

33.13

35.33

mmol/l

0.60

153

1014

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

6465

61261

1.07

5.14

5.1

3.71

3.75

ug/l

0.03

5721

54618

(40763480) Human metapneumovirus Ag [Presence] in Specimen

2.86

5.13

1.4

—

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

109

685

1.59

5.06

1.8

1.6

4.67

7.40

nmol/l

0.34

570

(3002619) Bacteria identified in Specimen by Culture

369

1.81

5.06

1.4

1.2

—

(3041008) Bicarbonate [Moles/volume] standard in Arterial cord blood

2.71

5.04

2.0

1.3

24.29

22.59

mmol/l

1.19

(3010370) Gastrin [Moles/volume] in Serum or Plasma

250

1.99

5.04

2.1

1.7

68.45

53.13

pmol/l

0.24

204

(40758355) Pancreatic polypeptide [Moles/volume] in Serum or Plasma

217

2.07

5.00

2.1

2.7

126.18

71.93

pmol/l

0.49

193

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

159

1087

1.46

5.00

1.2

1.1

43.49

42.34

mg/l

0.10

138

909

(3015822) Parvovirus B19 DNA [Presence] in Serum by NAA with probe detection

3.39

4.98

1.0

1.1

—

(3027944) Amphetamines [Presence] in Urine

427

3398

1.26

4.93

2.6

2.0

—

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

159

1093

1.45

4.87

1.3

1.2

29.70

25.09

u/l

0.46

148

917

(3034988) Calcium [Moles/volume] in Capillary blood

324

1.85

4.84

1.8

1.7

1.18

mmol/l

0.00

310

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

426

1.73

4.83

1.1

—

(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma

501

1.67

4.82

1.2

0.33

0.31

g/l

2.42

403

(3019420) Tryptase [Mass/volume] in Serum or Plasma

116

749

1.54

4.81

1.4

1.6

7.14

9.37

ug/l

1.50

106

675

(3020961) Endomysium IgA Ab [Titer] in Serum

795

6745

1.18

4.81

1.1

126.91

226.02

titre

0.88

161

(3016244) Insulin [Units/volume] in Serum or Plasma

111

713

1.55

4.72

3.1

3.3

33.88

25.93

mu/l

0.72

101

670

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

176

2.15

4.70

1.1

—

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

439

1.70

4.63

1.2

1.1

—

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

151

1040

1.45

4.60

1.1

324.52

281.84

mg/l

0.54

136

912

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

2474

22638

1.10

4.59

1.5

1.4

—

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

280

1.89

4.59

1.2

—

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

128

854

1.50

4.58

1.0

1.1

7.12

9.87

iu/ml

0.95

190

(3043649) Fibrin monomer [Presence] in Platelet poor plasma by Hemagglutination

3.47

4.57

1.1

1.0

—

(3002621) Streptococcal DNAse B [Units/volume] in Serum

128

2.34

4.51

1.1

—

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

229

1.96

4.37

1.1

1.2

—

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

237

1.93

4.31

1.2

—

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

181

1307

1.38

4.26

1.2

—

(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma

161

1140

1.41

4.26

1.1

1.0

303.99

287.76

mg/l

1.93

143

1017

(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma

473

1.64

4.25

1.2

113.72

111.66

0.27

413

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

228

1708

1.33

4.25

1.5

1.4

27.25

30.78

u/l

0.99

199

1385

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

376

1.72

4.22

1.1

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

115

767

1.50

4.17

1.2

1.3

—

(3024830) Lactate dehydrogenase 4/Lactate dehydrogenase.total in Serum or Plasma by Electrophoresis

2.73

4.14

1.1

7.83

8.58

0.53

(3007858) Lactate dehydrogenase 3/Lactate dehydrogenase.total in Serum or Plasma by Electrophoresis

2.73

4.14

1.1

19.97

21.42

0.59

(3023919) Lactate dehydrogenase 2/Lactate dehydrogenase.total in Serum or Plasma by Electrophoresis

2.73

4.14

1.1

37.46

36.52

0.60

(3043138) Epithelial cells.renal [#/area] in Urine by Computer assisted method

2.89

4.12

1.2

1.1

1.00

1.46

u/field

0.40

(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma

2.58

4.09

1.0

1.1

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

689

5863

1.18

4.08

1.7

1.6

—

(3012984) Norclozapine [Mass/volume] in Serum or Plasma

2.52

4.08

3.9

9.7

—

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

235

1.91

4.08

1.2

1.1

—

(3010144) Erythrocytes [#/volume] in Synovial fluid

229

1731

1.32

4.03

1.6

1.4

186220.11

133877.62

e6/l

0.42

159

1184

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

1217

10796

1.13

4.03

2.4

19.42

24.99

au/ml

1.29

743

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

591

1.55

3.98

1.1

1506.39

1529.10

miu/ml

0.07

591

(3017509) Phencyclidine [Presence] in Urine

105

2.37

3.93

2.2

1.4

—

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

356

1.71

3.87

1.1

—

(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma

125

2.23

3.84

1.0

1.1

13.96

10.82

u/l

0.20

125

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

119

2.26

3.82

1.1

—

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

192

1.97

3.81

1.1

—

(3008898) HLA-B27 [Presence]

519

4347

1.19

3.74

1.1

—

(3030862) Granulocytes [#/volume] in Cerebral spinal fluid

475

1.60

3.72

1.5

1.2

34.31

21.26

0.53

(3042585) Pyridoxine [Moles/volume] in Serum or Plasma

424

1.62

3.63

1.3

1.2

130.50

135.10

nmol/l

0.09

299

(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis

2.36

3.60

1.2

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

411

1.63

3.56

1.3

1.2

—

(3001186) Copper [Moles/volume] in Serum or Plasma

343

1.69

3.54

1.4

1.3

16.95

16.85

umol/l

0.06

310

(3031659) Enterovirus NOS Ab [Titer] in Cerebral spinal fluid

2.93

3.54

1.1

1.0

—

(3001019) Free T4 and TSH panel - Serum or Plasma

533

6239

0.85

3.54

1.6

1.7

—

(3026029) Penicillin V IgE Ab [Units/volume] in Serum

2.64

3.52

1.1

1.0

0.29

0.07

u/ml

0.46

(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method

124

2.17

3.49

1.3

1.5

—

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

131

931

1.40

3.47

1.2

1.1

37.12

26.61

u/l

1.03

125

820

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

1100

9795

1.12

3.47

1.3

41.36

56.61

au/ml

1.27

532

(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma

131

933

1.40

3.43

1.2

1.1

92.44

87.42

u/l

0.31

123

831

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

179

1.95

3.42

1.1

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

409

1.61

3.38

1.1

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

409

1.61

3.38

1.1

—

(3013637) Mi-2 Ab [Presence] in Serum

409

1.61

3.38

1.1

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

409

1.61

3.38

1.1

—

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

180

1.94

3.37

1.0

1.1

—

(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum

2.56

3.34

1.2

1.1

—

(3039443) Prostate specific Ag panel - Serum or Plasma

232

2926

0.79

3.28

1.6

—

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

121

2.14

3.27

1.1

1.0

—

(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen

2.53

3.25

1.6

1.5

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

314

1.68

3.25

1.3

1.2

—

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

109

762

1.43

3.20

1.1

1.05

1.06

u/l

0.06

359

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

397

3297

1.20

3.20

2.2

1.7

0.96

0.82

nmol/l

3.52

335

2728

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

184

1.90

3.18

1.1

—

(3048879) Bone marrow aspiration report

575

1.49

3.18

1.9

1.7

—

(3006969) Lambda light chains [Mass/volume] in Urine

2.85

3.16

1.1

1.0

0.16

0.03

g/l

—

(3020491) Glucose [Moles/volume] in Blood

165

1241

1.33

3.11

2.3

1.9

7.56

7.04

mmol/l

1.01

120

852

(3036071) Salmonella sp Ab [Titer] in Serum

436

1.55

3.06

1.1

—

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

120

861

1.39

3.06

1.2

1.1

—

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

191

1470

1.30

3.05

1.3

1.65

1.40

nmol/l

2.13

172

1326

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

103

720

1.43

3.05

1.0

—

(44786774) Adalimumab [Mass/volume] in Serum or Plasma

413

1.57

3.04

2.4

1.9

8.45

8.95

mg/l

0.33

333

(3016816) Cytomegalovirus IgG Ab [Presence] in Serum or Plasma

7.47

3.04

1.0

—

(3028468) Fragments [Presence] in Blood by Light microscopy

7.47

3.04

3.5

1.4

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

663

1.44

3.03

1.1

—

(46236287) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Pleural fluid by Immunoassay

2.37

3.02

1.1

1.2

1099.36

3201.75

ng/l

2.57

(3037297) Penicillin G IgE Ab [Units/volume] in Serum

2.57

3.01

1.1

1.0

0.15

0.03

u/ml

0.60

(40758292) HTLV I+II Ab panel - Serum

224

1.78

3.01

1.6

1.4

—

(43055514) Macroprolactin [Presence] in Serum or Plasma

239

1.75

2.99

2.0

1.5

—

(3036670) Protein [Mass/volume] in Synovial fluid

576

1.47

2.97

1.2

1.3

38.59

39.89

g/l

0.30

299

(3030313) Adrenal Ab [Titer] in Serum

100

2.19

2.95

1.0

—

(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method

107

2.14

2.92

1.0

—

(3042299) inFLIXimab [Mass/volume] in Serum or Plasma

402

1.56

2.91

2.5

3.1

7.99

7.42

mg/l

0.25

335

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

148

1.95

2.90

1.1

—

(3007463) Buprenorphine [Presence] in Urine

3.69

2.86

2.8

8.7

—

(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

2.20

2.86

1.1

—

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

2.24

2.83

1.2

1.1

—

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

15539

156824

0.95

2.81

4.3

4.1

1.40

1.29

mmol/l

51.36

13993

141666

(3013293) Extractable nuclear Ab [Presence] in Serum

244

1.72

2.81

1.5

1.6

—

(3033942) Copper [Moles/time] in 24 hour Urine

2.75

2.79

1.5

1.1

1.93

0.53

umol/24h

—

(43533860) Galactose-alpha-1,3-galactose (Alpha-Gal) IgE Ab [Units/volume] in Serum

158

1.89

2.75

1.0

0.01

0.35

u/ml

1.12

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

202

1.78

2.72

1.4

1.5

—

(3039114) Acanthocytes/1000 erythrocytes in Blood by Light microscopy

4.98

2.71

1.1

1.3

—

(3008994) Creatine kinase.BB [Enzymatic activity/volume] in Serum or Plasma by Electrophoresis

2.35

2.69

1.4

1.6

0.57

0.16

u/l

—

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood

301

1.62

2.68

6.3

7.0

—

(43055459) Dabigatran [Mass/volume] in Serum or Plasma

2.41

2.68

2.9

1.4

75.09

130.16

ug/l

1.17

(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection

2.49

2.67

1.4

1.3

—

(3034099) Cytomegalovirus Ab [Titer] in Cerebral spinal fluid

3.73

2.65

1.0

1.1

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

1011

9111

1.11

2.65

1.8

—

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

388

1.54

2.65

2.5

2.9

—

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

219

1.73

2.63

2.0

1.9

16.64

16.72

umol/l

0.01

219

(40760548) Muscle specific receptor tyrosine kinase Ab [Units/volume] in Serum by Immunoassay

257

1.67

2.62

1.0

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

1120

10157

1.10

2.60

1.9

—

(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum

704

6223

1.13

2.59

1.1

1.50

8.13

u/ml

0.86

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

163

1260

1.29

2.59

1.2

—

(3034092) Cytoplasmic Ig cells/100 cells in Blood

191

1.77

2.57

11.3

8.1

—

(3041678) Intrinsic coagulation system thromboelastography panel - Blood

2.14

2.57

1.3

—

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

111

814

1.36

2.54

1.6

—

(3005411) Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma

321

1.58

2.54

2.4

1.8

2.86

2.22

ug/l

0.56

183

(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma

2.18

2.54

1.6

1.1

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

235

2862

0.82

2.52

1.5

—

(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid

2.21

2.50

1.0

—

(40757578) FLT3 gene targeted mutation analysis in Bone marrow by Molecular genetics method

2.59

2.50

1.0

1.1

—

(3027923) C peptide [Moles/volume] in Serum or Plasma

122

911

1.34

2.49

1.4

1.39

1.17

nmol/l

1.07

697

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

135

1023

1.32

2.49

1.2

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

105

1411

0.74

2.48

1.5

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

355

1.54

2.47

1.2

—

(3050794) Legionella sp Ab [Presence] in Serum

143

1.88

2.46

1.1

—

(3007916) DNA double strand Ab [Titer] in Serum

194

1.75

2.46

1.7

1.3

293.33

106.33

titre

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

308

2570

1.20

2.45

1.7

1.6

—

(3024316) Viscosity of Plasma

2.19

2.44

2.4

1.7

1.84

1.61

mpas

—

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

610

1.41

2.42

3.6

2.9

29.54

28.05

umol/l

0.71

458

(3025577) Chromium [Mass/volume] in Blood

152

1177

1.29

2.41

2.0

2.38

2.34

ug/l

0.04

113

985

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

611

1.40

2.40

1.1

228.60

566.80

ng/l

0.95

143

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

393

3356

1.17

2.40

1.3

225.20

218.74

miu/ml

0.11

121

1400

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

133

1013

1.31

2.39

1.2

—

(3011325) HIV 1+2 Ab [Presence] in Serum

2.28

2.38

1.1

1.0

—

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

234

1.66

2.37

2.7

2.6

0.72

0.53

u/field

0.55

234

(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay

2.33

2.36

1.1

1.0

—

(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid

2.10

2.35

1.0

—

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

212

1.69

2.34

1.3

1.6

—

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

169

1333

1.26

2.32

1.8

1.7

—

(3035933) Granulocytes/100 leukocytes in Blood

330

1.54

2.29

1.9

1.5

—

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

280

2335

1.20

2.28

1.1

59.69

5258.36

iu/ml

0.58

478

(3042552) Rheumatoid factor [Units/volume] in Pleural fluid

163

1.77

2.23

1.1

9.30

16.90

iu/ml

—

(3032185) JC virus DNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection

5.53

2.20

2.6

1.4

—

(3023709) Somatotropin [Mass/volume] in Serum or Plasma

439

1.45

2.19

1.5

2.2

0.82

1.01

ug/l

0.49

412

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

2004

21196

0.94

2.18

1.4

—

(3013166) Neutrophils/100 leukocytes in Synovial fluid

556

1.40

2.17

1.6

1.3

61.40

57.39

0.47

474

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

440

1.45

2.17

1.2

—

(3032567) Hepatitis B virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

441

1.45

2.15

1.2

1.7

—

644.20

iu/ml

—

(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma

138

1074

1.28

2.14

1.7

1.9

17.37

16.67

nmol/l

0.46

132

995

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

2408

22700

1.06

2.14

10.8

7.6

—

(3026470) Cobalt [Mass/volume] in Blood

153

1207

1.26

2.13

2.0

3.65

3.83

ug/l

0.12

136

1106

(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection

2.99

2.13

2.1

1.2

—

(3035611) Eosinophils/100 leukocytes in Synovial fluid

123

1.86

2.08

2.0

1.7

1.11

0.67

0.35

(3008116) Ketones [Moles/volume] in Urine by Test strip

363

1.48

2.07

1.3

—

(3036048) Francisella tularensis Ab [Titer] in Serum

355

1.49

2.06

1.2

—

933.33

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

698

1.34

2.06

1.2

—

(3016273) Islet cell 512 Ab [Units/volume] in Serum

2.12

2.05

1.0

1.1

—

(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis

554

1.39

2.05

1.3

1.4

15.04

15.94

pmol/l

0.85

459

(3027456) Digoxin [Moles/volume] in Serum or Plasma

488

4289

1.14

2.05

3.2

0.79

0.81

nmol/l

0.60

357

3328

(3019768) Coxiella burnetii Ab [Presence] in Serum

1.97

2.02

1.4

1.2

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

573

1.37

2.01

1.1

1.2

—

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

124

962

1.29

2.00

1.1

4.70

7.18

nmol/l

0.36

201

(3034614) HLA Ag [Interpretation]

3.06

2.00

1.4

1.3

—

(3003752) BK virus DNA [Units/volume] (viral load) in Urine by NAA with probe detection

2.80

1.98

2.1

1.4

—

(3032743) Legionella sp IgG Ab [Presence] in Serum

111

1.88

1.97

1.0

1.1

—

(3040370) OLANZapine [Moles/volume] in Serum or Plasma

491

1.40

1.97

3.2

2.3

141.68

149.30

nmol/l

0.30

424

(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay

1.99

1.97

1.0

1.1

—

(40762814) Titanium [Mass/volume] in Blood

335

1.49

1.96

2.4

2.2

3.06

3.61

ug/l

0.76

126

(36304052) Adalimumab Ab [Units/volume] in Serum or Plasma

327

1.49

1.96

2.2

1.6

205.03

100.74

au/ml

—

(40761593) Coagulation factor VIII Ab [Presence] in Platelet poor plasma by Immunoassay

4.53

1.93

1.4

1.5

—

(1175556) inFLIXimab Ab [Units/volume] in Serum by Immunoassay

377

1.45

1.93

2.2

2.4

203.84

120.09

au/ml

0.56

(3033923) Metanephrine [Moles/time] in 24 hour Urine

377

1.45

1.93

1.2

1.1

0.64

0.83

umol/24h

0.49

176

(1002224) Polysomnography panel

637

5712

1.11

1.93

1.1

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

1035

0.74

1.91

1.5

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

102

777

1.31

1.90

1.1

—

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

449

3949

1.13

1.89

1.1

5.12

8.44

u/ml

1.12

414

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

242

1.56

1.88

1.1

—

(3018133) Calcium [Moles/volume] in Urine

203

1.62

1.88

1.9

1.6

2.75

2.68

mmol/l

0.07

178

(3012215) Mononuclear cells/100 leukocytes in Synovial fluid

454

1.40

1.88

1.4

1.3

36.64

35.65

0.08

302

(3002079) Sodium [Moles/time] in 24 hour Urine

720

1.32

1.85

1.3

1.2

157.46

159.89

mmol/24h

0.10

720

(21494567) Legionella sp IgM Ab [Presence] in Serum

114

1.83

1.84

1.0

1.1

—

(44813793) Dust mix specific IgE antibody measurement

130

1029

1.26

1.81

1.1

—

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

191

1577

1.21

1.80

1.4

0.39

0.32

nmol/l

0.37

136

1166

(3038177) Helicobacter pylori Ab [Presence] in Serum

291

2494

1.16

1.79

1.3

1.2

—

(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma

3.03

1.79

1.7

2.0

—

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

199

1.60

1.76

1.0

1.1

—

(3003985) Beta hydroxybutyrate [Moles/volume] in Serum or Plasma

154

1.68

1.72

2.2

0.70

0.95

mmol/l

0.57

101

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

232

1.55

1.72

1.1

—

(3033086) Enterovirus NOS Ab [Titer] in Serum

2.21

1.72

1.0

—

(37021550) Renin [Units/volume] in Plasma --upright

354

1.44

1.71

1.3

1.2

125.29

64.88

mu/l

0.78

258

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

375

1.41

1.62

1.2

1.3

—

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

153

1252

1.22

1.62

1.2

9.10

9.05

mmol/l

0.04

145

1191

(3039183) Clostridium tetani toxoid IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

3.56

1.61

1.2

1.0

—

(3001729) Color of Synovial fluid

150

1.66

1.60

1.8

1.6

—

(3029396) Erythrocyte agglutination [Presence] in Blood

197

1.57

1.59

2.1

2.5

—

(40763641) Cell count and Differential panel - Peritoneal dialysis fluid

2.68

1.57

2.9

5.0

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

254

2186

1.16

1.53

1.1

1.00

1.74

u/ml

1.80

127

1067

(3004437) Lymphocytes/100 leukocytes in Peritoneal fluid

160

1.62

1.52

2.2

2.0

72.33

58.17

1.05

101

(3001556) Androgen free Index in Serum or Plasma

1.96

1.52

2.4

1.2

—

(21494671) JAK2 gene exon 14 targeted mutation analysis in Bone marrow by Molecular genetics method

3.32

1.51

1.0

1.1

—

(3034552) Adenosine deaminase [Enzymatic activity/volume] in Cerebral spinal fluid

1.83

1.43

1.1

1.0

3.20

3.53

u/l

—

(3023693) von Willebrand factor (vWf) multimers in Platelet poor plasma by Immunoblot

3.11

1.43

1.0

1.3

—

(3045519) Venlafaxine [Moles/volume] in Serum or Plasma

2.11

1.42

1.4

409.65

518.98

nmol/l

0.36

(3009461) 5-Hydroxyindoleacetate [Moles/time] in 24 hour Urine

2.11

1.42

2.2

1.1

—

(3004268) Protein electrophoresis panel - Cerebral spinal fluid

2.72

1.42

1.7

1.1

—

(40768793) Breast Pathology biopsy report

399

3559

1.12

1.42

1.3

—

(3003888) Timothy IgE Ab [Units/volume] in Serum

227

1952

1.16

1.41

1.0

1.1

4.00

4.41

u/ml

0.16

120

931

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

500

4522

1.10

1.38

2.6

2.2

147.97

108.06

ug/min

0.78

295

2634

(3021691) Plasmodium malariae Ab [Titer] in Serum

2.93

1.35

1.6

2.2

—

(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis

158

1.58

1.34

9.0

5.1

—

(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma

450

4055

1.11

1.34

1.9

1.7

39.74

42.93

nmol/l

2.53

442

3900

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

381

1.36

1.34

1.9

1.5

123.69

122.78

ng/l

0.01

381

(3010726) Horse dander IgE Ab [Units/volume] in Serum

201

1721

1.16

1.34

1.1

1.18

1.27

u/ml

0.10

100

827

(3018688) Ampicillin IgE Ab [Units/volume] in Serum

2.08

1.29

1.2

1.0

—

(3026480) Teichoate Ab [Titer] in Serum

168

1.54

1.28

1.1

—

2.00

—

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

176

1.53

1.28

1.0

1.1

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

146

1223

1.19

1.27

1.5

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

105

852

1.23

1.27

1.4

1.3

—

(3000285) Sodium [Moles/volume] in Blood

234

1.45

1.26

1.2

—

(3027300) Silver Birch IgE Ab [Units/volume] in Serum

319

1.37

1.23

1.1

1.0

13.39

10.51

u/ml

0.23

165

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

553

1.28

1.23

1.1

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

105

1270

0.82

1.22

1.9

1.7

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

216

1876

1.15

1.21

1.0

1.1

0.91

1.09

u/ml

0.30

756

(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer

397

1.33

1.21

2.3

2.5

6.61

7.77

mmol/l

2.52

248

(3036005) Urine sediment comments by Light microscopy Narrative

2.62

1.21

1.0

1.1

—

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

116

1.63

1.19

1.1

1.2

—

(36303858) Crystals [Presence] in Urine

2.30

1.18

1.0

1.2

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

142

1662

0.85

1.16

1.4

1.5

—

(3042847) Granulocytes/100 leukocytes in Cerebral spinal fluid

133

1.57

1.15

1.1

1.2

24.50

26.47

—

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

451

4906

0.91

1.14

1.8

1.7

4.98

3.96

mg/l

1.14

371

3617

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

134

1.56

1.12

1.2

1.1

—

(3032492) JC virus DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection

2.32

1.12

1.0

1.1

—

(40761872) Peanut recombinant (rAra h) 2 IgE Ab [Units/volume] in Serum

142

1.54

1.12

1.0

0.01

0.75

u/ml

0.67

104

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

328

2943

1.11

1.12

2.1

1.9

186.42

196.62

pmol/l

1.05

312

2750

(3010937) Rubella virus Ab [Presence] in Serum

1.89

1.10

1.1

—

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

631

0.77

1.03

1.4

—

(3025443) Phadiatop IgE Ab [Units/volume] in Serum

676

1.22

1.02

1.1

7.10

6.65

u/ml

0.07

102

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

15741

155607

1.03

1.01

6.6

6.1

40.86

40.29

mmol/mol

10.94

14489

142503

(3009015) Lactate [Moles/volume] in Synovial fluid

204

1.42

1.00

1.2

1.3

6.25

6.33

mmol/l

0.02

(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma

1.94

0.96

1.4

1.1

1.14

2.72

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

113

1320

0.85

0.95

1.4

1.5

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

791

7428

1.06

0.94

1.1

—

(3020951) Lymphocytes/100 leukocytes in Cerebral spinal fluid

241

1.36

0.94

1.2

1.3

59.44

52.77

0.33

107

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

2263

21800

1.04

0.93

4.5

4.7

31.58

32.80

6.20

1629

14637

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

149

1.47

0.93

1.1

—

(40761873) Peanut recombinant (rAra h) 1 IgE Ab [Units/volume] in Serum

1.64

0.92

1.0

0.00

0.20

u/ml

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

207

1835

1.12

0.92

1.1

4.99

3.89

u/ml

0.26

762

(3015183) Erythrocyte sedimentation rate

631

1.22

0.92

1.2

—

(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy

1.61

0.92

1.1

—

(3025130) Human papilloma virus identified in Specimen

182

1603

1.13

0.90

1.6

1.7

—

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

110

934

1.17

0.90

2.3

2.1

123.45

118.56

ug/min

0.02

213

(3027231) Wheat IgE Ab [Units/volume] in Serum

218

1.37

0.89

1.0

0.40

2.06

u/ml

0.71

177

(3050129) First trimester maternal screen panel - Serum or Plasma

169

1902

0.88

0.87

1.5

1.4

—

(3005033) Fetal Nuchal fold Thickness US

110

1275

0.86

1.4

—

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

177

1.41

0.86

1.4

1.1

1.89

1.73

umol/24h

0.37

177

(3018562) Neutrophils/100 leukocytes in Cerebral spinal fluid

120

1.49

0.83

1.2

1.4

30.73

36.05

0.18

(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method

120

1.49

0.83

1.1

5.0

—

(42528717) Cashew nut recombinant (rAna o) 3 IgE Ab [Units/volume] in Serum

1.62

0.83

1.0

0.14

0.67

u/ml

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

796

0.82

0.83

1.1

1.0

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

111

1278

0.86

0.81

1.4

—

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

163

1.41

0.80

1.0

—

(3020356) Listeria sp identified in Specimen by Organism specific culture

1.72

0.78

1.0

1.1

—

(3007542) Rye IgE Ab [Units/volume] in Serum

1.72

0.78

1.0

1.1

3.95

0.15

u/ml

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

137

1547

0.88

0.77

1.4

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

434

4631

0.93

0.77

1.8

—

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

156

1.40

0.77

1.0

1.1

—

(3022475) Manganese [Moles/volume] in Blood

1.52

0.77

1.3

—

(3004446) Plasmodium sp identified in Blood by Light microscopy

123

1.46

0.76

2.2

2.5

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

137

1544

0.88

0.76

1.4

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

1022

10629

0.96

0.75

1.4

1.3

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

348

3737

0.93

0.74

1.4

1.5

—

(21493619) Chromosome 12 trisomy and chromosome region 11q22.3 and 13q14 and 17p13.1 deletion in Blood or Tissue by FISH

1.53

0.73

1.1

1.2

—

(4146454) Self-monitoring of blood glucose

187

2065

0.90

0.73

2.5

2.7

—

(40771901) t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript/control transcript (International Scale) [# Ratio] in Blood or Tissue by Molecular genetics method

1.59

0.73

12.6

8.6

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

138

1550

0.89

0.73

1.4

—

(3000034) Microalbumin [Mass/volume] in Urine

154

1718

0.89

0.73

3.3

2.9

85.51

44.95

mg/l

1.08

118

1226

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

138

1549

0.89

0.72

1.4

—

(3016330) Potassium [Moles/time] in 24 hour Urine

227

1.32

0.72

1.3

1.2

—

85.49

—

(3041672) Baker's yeast Ab [Presence] in Serum

1.66

0.71

1.1

1.0

—

(3010657) Triiodothyronine (T3) Free [Mass/volume] in Serum or Plasma by Dialysis

1.74

0.71

1.9

1.5

—

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

105

1197

0.87

0.70

1.0

37.94

42.79

ng/l

0.87

804

(40767665) Peanut recombinant (rAra h) 9 IgE Ab [Units/volume] in Serum

1.57

0.70

1.0

0.01

0.58

u/ml

—

(3016284) Epstein Barr virus nuclear Ab [Units/volume] in Serum

1.91

0.70

1.0

1.2

—

(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright

406

1.23

0.70

1.1

402.31

289.84

pmol/l

0.78

293

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

105

1194

0.87

0.68

1.0

746.40

714.61

ng/l

0.34

790

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

4376

44336

0.98

0.66

1.7

1.6

1.50

1.35

mmol/l

17.98

3626

36857

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

105

1188

0.88

0.65

1.0

295.67

329.57

ng/l

0.77

815

(3010015) Selenium [Moles/volume] in Serum or Plasma

111

1.44

0.64

2.2

1.9

1.32

1.37

umol/l

0.26

100

(3006270) Folate [Moles/volume] in Blood

178

1608

1.10

0.63

1.2

316.10

345.42

nmol/l

0.79

136

1293

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

652

0.84

0.62

1.2

—

(3022689) Creatine [Moles/volume] in Urine

511

0.82

0.62

1.9

1.5

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

1136

10910

1.04

0.62

1.3

1.2

—

(3016184) Myelin associated glycoprotein Ab [Units/volume] in Serum

104

1.44

0.61

1.2

1.4

—

13114.83

—

(3002523) Influenza virus A Ag [Presence] in Specimen

203

1851

1.09

0.61

1.2

1.1

—

(3040794) Aluminum [Moles/volume] in Urine

0.00

0.60

0.0

1.1

—

(3032868) Hemoglobin electrophoresis panel in Blood

113

1.41

0.59

2.0

1.5

—

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

197

0.71

0.59

1.1

1.0

—

(3020650) Glucose [Presence] in Urine

397

1.20

0.59

1.4

—

(3005011) Chlamydia sp Ab [Titer] in Serum

200

1.29

0.58

1.7

—

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

140

1.35

0.57

1.1

—

(3014591) Smooth Alder IgE Ab [Units/volume] in Serum

1.66

0.56

1.0

—

(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method

123

1.38

0.56

1.1

—

(3014599) Egg white IgE Ab [Units/volume] in Serum

654

0.85

0.56

1.1

1.0

0.75

0.70

u/ml

0.07

157

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

115

1025

1.12

0.55

1.2

—

(40758358) Immune stain study

1.50

0.55

1.0

—

(43055190) Macrophages [#/area] in Urine sediment by Microscopy high power field

1.44

0.54

1.2

1.3

1.00

1.13

u/field

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

513

1.16

0.53

1.2

1.1

—

(3003740) Influenza virus B Ag [Presence] in Specimen

202

1857

1.08

0.53

1.2

1.1

—

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

155

1409

1.10

0.52

4.3

5.0

50.37

122.37

u/ml

1.48

432

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

134

1.34

0.51

3.3

2.1

—

(3019298) Eosinophils/100 leukocytes in Peritoneal fluid

1.49

0.51

1.0

1.4

1.40

0.29

—

(3020874) Milk IgE Ab [Units/volume] in Serum

678

0.87

0.50

1.1

1.0

4.35

0.95

u/ml

0.40

221

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

412

4318

0.95

0.49

1.4

1.3

—

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

153

1.30

0.49

1.2

—

(3027318) Ethylene glycol [Moles/volume] in Serum or Plasma

1.55

0.48

1.0

1.2

—

mmol/l

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

361

1.19

0.48

1.5

1.2

—

(4034850) Laboratory test

591

5641

1.04

0.48

15.9

10.6

—

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

456

1.16

0.45

3.0

1.6

—

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

184

1972

0.93

0.45

1.3

1.2

7.91

7.48

mmol/l

1.02

160

1698

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

1078

0.90

0.43

1.4

251.80

165.15

pmol/l

0.44

1078

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

1729

16845

1.02

0.42

1.6

—

(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification

752

1.11

0.41

4.5

5.3

45.18

5419.90

u/ml

0.57

130

(3004347) Hepatitis D virus Ab [Presence] in Serum

1.51

0.41

1.0

—

(3006462) Nitrate [Presence] in Urine

857

1.10

0.41

3.8

3.5

—

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

132

1211

1.09

0.40

1.0

0.19

0.44

u/ml

0.59

338

(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum

1.31

0.39

1.0

—

(3045462) Protein/Creatinine [Ratio] in Urine

1.36

0.39

2.3

3.5

110.93

48.60

g/mol

0.45

(42528783) Honey bee recombinant (rApi m) 10 IgE Ab [Units/volume] in Serum

0.00

0.39

0.0

1.0

—

(3041806) Other cells [#/volume] in Blood by Manual count

206

1.21

0.36

1.8

1.5

—

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

101

922

1.09

0.36

1.4

1.5

2.38

4.24

ug/l

2.01

731

(3051659) 25-hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

116

1.29

0.36

1.0

1.1

16.80

13.93

nmol/l

—

(3009542) Hematocrit [Volume Fraction] of Blood

18440

183195

1.02

0.35

40.5

22.4

39.38

39.98

1.56

17336

169970

(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay

1.39

0.35

1.0

—

(3037577) Monocytes/100 leukocytes in Cerebral spinal fluid

108

1.29

0.34

1.1

1.5

7.89

13.79

—

(3013762) Body weight Measured

1.36

0.34

1.7

1.1

—

(3027974) Hepatitis B virus e Ag [Presence] in Serum

1.36

0.33

1.0

1.7

—

(3040562) Leukocytes [#/volume] in Peritoneal dialysis fluid by Manual count

1.33

0.33

6.5

9.6

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

535

5155

1.03

0.32

1.9

1.8

—

(40765089) Chromosome analysis panel - Blood by G-banded

219

0.82

0.32

1.0

—

(3023430) Cat dander IgE Ab [Units/volume] in Serum

149

1391

1.07

0.32

1.0

1.1

4.43

3.46

u/ml

0.18

537

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

388

0.87

0.30

1.4

1.5

—

(46234826) Other cells/100 leukocytes in Peritoneal fluid by Manual count

129

1.24

0.29

2.3

1.9

7.17

17.97

—

(3028717) Thiamine [Mass/volume] in Blood

175

1.19

0.29

1.2

1.1

—

(3027570) Oxalate [Moles/time] in 24 hour Urine

1.29

0.27

1.8

1.4

382.91

313.34

umol/24h

0.40

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

892

0.93

0.27

1.3

1.49

1.55

g/l

0.98

892

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

4948

48886

1.01

0.25

4.3

4.4

21.59

22.12

1.67

2490

24501

(3013945) Hepatitis B virus e Ab [Presence] in Serum

1.23

0.25

1.0

1.7

—

(3007461) Platelets [#/volume] in Blood

18440

183293

1.01

0.25

40.1

22.4

249.43

246.81

e9/l

5.36

18059

177867

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

433

1.10

0.25

1.6

10.23

8.85

ug/l

0.84

433

(1617658) Protocol used for examination of sentinel lymph nodes

132

1246

1.06

0.23

1.0

1.1

—

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

294

0.88

0.22

1.1

1.2

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

3536

34908

1.01

0.22

3.0

3.1

0.82

0.79

ug/l

0.64

2501

23768

(3008607) Semen analysis panel

1.21

0.22

1.0

1.3

—

(3000690) Aldosterone [Moles/time] in 24 hour Urine

0.00

0.21

0.0

1.2

—

36.40

—

(3002853) Influenza virus B Ab [Titer] in Serum

0.00

0.21

0.0

1.0

—

(42870560) Thyrotropin [Units/volume] in Cord blood

0.00

0.21

0.0

1.0

—

12.98

—

(3027505) Alpha-1-Fetoprotein [Units/volume] in Amniotic fluid

0.00

0.21

0.0

1.0

—

(3003095) Rheumatoid factor [Units/volume] in Synovial fluid

0.00

0.21

0.0

1.0

—

(40763476) Honey bee phospholipase A2 recombinant (rApi m) 1 IgE Ab [Units/volume] in Serum

1.19

0.21

1.0

—

(40760087) Plasmodium sp Ab [Presence] in Serum by Immunofluorescence

0.00

0.21

0.0

1.0

—

(3015076) Soybean IgE Ab [Units/volume] in Serum

572

0.92

0.21

1.1

1.0

0.51

0.78

u/ml

0.20

151

(3020934) Sesame Seed IgE Ab [Units/volume] in Serum

0.00

0.21

0.0

1.0

—

0.39

—

(3009677) Dengue virus Ab [Presence] in Serum

1.24

0.20

1.2

—

(40760435) Tropomyosin IgE Ab [Units/volume] in Serum

126

1.19

0.20

1.1

1.0

—

(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture

111

0.81

0.20

1.0

1.1

—

(3010813) Leukocytes [#/volume] in Blood

18446

183410

1.01

0.19

40.1

22.4

7.10

6.79

e9/l

36.67

18026

177320

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

466

0.92

0.19

1.4

1.8

—

(3035941) MCH [Entitic mass]

18441

183366

1.01

0.19

39.9

22.2

30.24

30.38

17.23

18231

180204

(3033888) Pepsinogen I [Mass/volume] in Serum or Plasma

193

1.14

0.18

1.0

1.1

76.11

80.39

ug/l

0.17

146

(3027401) Testosterone Free/Testosterone.total in Serum or Plasma

1.16

0.17

1.4

1.3

1.46

1.34

—

(3011335) Digoxin [Mass/volume] in Serum or Plasma

185

1.13

0.17

2.3

—

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

162

0.86

0.17

1.4

1.7

—

(3024731) MCV [Entitic volume]

18441

183388

1.01

0.17

40.0

22.3

91.63

91.35

12.09

18230

180222

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

106

1008

1.05

0.16

5.6

6.5

—

(3026361) Erythrocytes [#/volume] in Blood

18441

183400

1.01

0.15

40.1

22.4

4.36

4.45

e12/l

93.33

18013

177305

(3016426) Methylmalonate [Moles/volume] in Serum or Plasma

1.09

0.15

1.0

1.1

218.50

252.57

nmol/l

—

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

139

0.86

0.14

1.1

1.0

—

(3000963) Hemoglobin [Mass/volume] in Blood

18443

183437

1.01

0.14

40.4

22.5

130.70

134.43

g/l

187.46

18245

180278

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

16330

162816

0.99

0.14

5.2

4.8

6.08

6.01

mmol/l

7.71

14808

146961

(3022640) Eosinophils/100 leukocytes in Cerebral spinal fluid

1.18

0.14

1.0

1.4

0.17

1.10

—

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

467

0.94

0.13

1.1

—

(3014133) Dog dander IgE Ab [Units/volume] in Serum

155

1496

1.03

0.13

1.1

2.70

3.39

u/ml

0.31

674

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

414

4049

1.02

0.13

1.9

1.8

—

(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen

153

1.11

0.10

5.8

—

(3012494) Peanut IgE Ab [Units/volume] in Serum

329

0.94

0.09

1.1

1.0

0.75

1.75

u/ml

0.69

165

(40768800) Prostate Pathology biopsy report

392

3849

1.01

0.09

1.2

—

(40761995) Spermatozoa Progressive [#/volume] in Semen

154

1.10

0.09

2.9

—

(3003338) MCHC [Mass/volume]

13827

137492

1.00

0.09

34.9

19.9

329.72

331.95

g/l

144.19

13710

136237

(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

1.09

0.08

1.0

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

692

1.04

0.08

1.3

1.2

—

(3045781) Inhibin B [Mass/volume] in Serum or Plasma

281

1.06

0.08

1.9

3.1

106.78

130.06

ng/l

0.12

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

326

0.95

0.07

1.1

1.0

—

(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma

1.05

0.07

1.3

1.2

—

(3003721) Smooth muscle Ab [Units/volume] in Serum

100

0.90

0.06

1.0

1.1

—

2.02

—

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

207

1.06

0.05

1.3

1.1

—

(4094501) Cardiovascular stress test using bicycle ergometer

465

4597

1.01

0.04

1.1

—

(4212803) Bone marrow aspirate examination

182

1.04

0.01

1.1

—

(43534046) Estradiol (E2) [Moles/volume] in Serum or Plasma by High sensitivity method

153

1.04

0.01

1.3

1.2

0.16

0.26

nmol/l

—

101

(46235168) Fasting glucose [Moles/volume] in Blood

193

0.98

0.00

2.6

8.11

7.46

mmol/l

—

(3051101) Glucose [Moles/volume] in Cord blood

356

1.01

0.00

5.3

5.9

—

(3025504) Homovanillate [Moles/time] in 24 hour Urine

0.00

-0.00

0.0

1.0

—

(3008896) Cortisol [Moles/volume] in Urine

0.00

-0.00

0.0

1.0

—

(3005117) Influenza virus A Ab [Titer] in Serum

0.00

-0.00

0.0

1.0

—

(3004560) Lymphocytes [#/volume] in Cerebral spinal fluid

0.00

-0.00

0.0

1.0

—

(3020123) Porphyrins [Interpretation] in Serum or Plasma

0.91

-0.00

1.5

1.1

—

(3037441) Creatinine [Moles/volume] in Peritoneal dialysis fluid

1.01

-0.00

5.5

5.7

433.33

438.93

umol/l

—

(3008799) Glucose [Moles/volume] in Serum or Plasma --30 minutes post dose glucose

0.98

-0.00

1.0

1.1

8.28

8.17

mmol/l

—

(3035153) Lemon IgE Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.1

—

(3000219) Insulin receptor Ab [Presence] in Serum

0.00

-0.00

0.0

1.0

—

(3033463) Neutrophils [#/volume] in Cerebral spinal fluid

0.00

-0.00

0.0

1.0

—

(36031836) Tocilizumab [Mass/volume] in Serum

0.00

-0.00

0.0

1.2

—

19.07

—

(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method

0.96

-0.00

1.0

—

(40761895) Polymorphonuclear cells/100 leukocytes in Peritoneal dialysis fluid

0.00

-0.00

0.0

2.5

—

(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture

0.94

-0.00

5.0

3.4

—

(3009220) Epithelial cells.squamous [#/volume] in Urine sediment

0.00

-0.00

0.0

1.2

—

2.87

—

(3003157) Bacteria [#/volume] in Mother's milk

0.00

-0.00

0.0

9.6

—

Mortality – FinRegistry

↥

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

Relationships between endpoints

↥

Index endpoint: I9_DVTANDPULM – DVT of lower extremities and pulmonary embolism

GWS hits: -

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

≡ Risteys

R13

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

DVT of lower extremities and pulmonary embolism

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

All original rules

Similar endpoints

Case counts by codes

Upset plot

Case counts by code for DVT of lower extremities and pulmonary embolism (I9_DVTANDPULM)

Summary Statistics

-FinRegistry-

-FinnGen-

Key figures

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Relationships between endpoints